CN102617526B - Sesterterpene compounds Hippolide J and its production and use - Google Patents

Sesterterpene compounds Hippolide J and its production and use Download PDF

Info

Publication number
CN102617526B
CN102617526B CN201110145099.0A CN201110145099A CN102617526B CN 102617526 B CN102617526 B CN 102617526B CN 201110145099 A CN201110145099 A CN 201110145099A CN 102617526 B CN102617526 B CN 102617526B
Authority
CN
China
Prior art keywords
extract
sponge
hippolide
medicinal extract
obtains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110145099.0A
Other languages
Chinese (zh)
Other versions
CN102617526A (en
Inventor
朴淑娟
林厚文
陆海燕
庞涛
陈万生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Changzheng Hospital
Original Assignee
Shanghai Changzheng Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Changzheng Hospital filed Critical Shanghai Changzheng Hospital
Priority to CN201110145099.0A priority Critical patent/CN102617526B/en
Publication of CN102617526A publication Critical patent/CN102617526A/en
Application granted granted Critical
Publication of CN102617526B publication Critical patent/CN102617526B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to medical technical field, be specifically related to a kind of sesterterpene compounds Hippolide J being separated to and its production and use from marine animal sponge. With ethanol diacolation extraction sponge routinely, concentrating and separating purifying obtains Hippolide J, and its molecular formula is C25H36O3; Preparation technology is simple, yield is high, and stable in properties is used the quality of the pharmaceutical preparations of preparation stable, convenient quality control, and production cost is lower, is convenient to suitability for industrialized production; This compound all shows and suppresses active human lung cancer cell A549, human cervical carcinoma cell Hela; can be used for preparing antineoplastic; and evident in efficacy; safety and low toxicity; easy to use; one-object-many-purposes, its raw material sources are abundant, inexpensive, for prevention, diagnosis, detection, protection, treatment and Effect of Anti tumour, anti-diabetic and anti-obesity and directly related disease thereof provide a kind of new medicament sources and safe raw material.

Description

Sesterterpene compounds Hippolide J and its production and use
Technical field
The present invention relates to medical technical field, specifically relate to derive from a kind of compound of marine animal and carryGet the technical fields such as separation, use, more particularly relate to a kind of compound being separated to from marine animal sponge andPreparation method and purposes, more specifically relate to the black amber terpene of a kind of sesterterpene compounds (HippolideJ) and system thereofPreparation Method and purposes.
Background technology
(1) research overview of sponge
1, general introduction
Sponge (English name: SpongiatiaorSponge, Latin name: PhylumPorifera) for porous movingThe common name of thing, belongs to animal kingdom paleontology invertebrate paleontology Poritera (Porifera). Poritera is largeThe general designation of approximately 5,000 kinds of original multicellular aquatic animals. Be fresh water production except spongilla sp belongs to (Spongilla) approximately 20 kinds, divide equallyCloth is in the intertidal zone to 8 of ocean, and 500 meters of (more than 28,000 feet) depths, seek set life.
Sponge just lived in ocean before 200,000,000 years, of a great variety, widely distributed, had developed into so far kind more than 10,000,Accounting for 1/15 of marine animal kind, is one huge " family ", wherein nearly 1/3 lives near the marine site of Australia, isIn ocean except coral the second a large amount of marine animal. , all there is the figure of sponge in ocean everywhere, from intertidal zone to deep-sea, fromTropical Ocean has distribution to Antarctic Ice sea. Sponge not only can live in ocean, can also live in river and lake. PerhapsBeing that sponge health is soft mostly lives in ocean like continuous, and the name of " sponge " is come therefrom.
Because sponge is often branch shape, and can not move, be regarded plant by people in the past. Within 1755, just someone describes itThere is the feature of animal. Within 1765, observe by the keying of current and the blasthole of sponge, confirmation sponge is animal. SpongeStructure, function and growth are different from other animals. Spongia does not have mouth, there is no gastrovascular cavity, there is no central nervous system, its yetIn body wall, having countless apertures is its filter food and passage of breathing, is the many cells such as low the most ancient, the simplest and the most originalAnimal.
By to sponge genetic test and with the gene comparisons of other animals (fly, fish, the frog and people), scientist thinks,Animal ancestors were the earliest sponges, and they have been survived at least 5.6 hundred million years on earth, apart from the spongeization of modern about approximately 500,000,000 yearsStone is also found, but complete cavernous body bone is very rare in fossil record. Cavernous body be by calcareous or siliceous spur andThe sponge support of cutin forms. If sponge is fished for up from water, dig pit and bury by the sea, wait to wait the meat that rots, surplusThe lower fibrous bone interweaving, then pass through rinsing, be only our daily being seen sponge.
Sponge secondary metabolite is rich and varied, wherein contains and has in a large number antitumor, antiviral, antibacterial, anti-inflammatory and exempt fromThe different bioactive compounds such as epidemic disease adjusting are the focuses of marine nature products chemistry research always.
2, form and structure
Sponge is the simplest multicellular animals of structure in the world. Saying that it is simple, is because it had not both had head, does not also haveTail, does not have trunk and four limbs, more there is no nerve and organ. Spongia originates in seawater mostly, and minority is lived in fresh water, because ofHealth is soft and gain the name.
The sponge overwhelming majority inhabits benthos, anchors at different waters. Although sponge belongs to animal, it can notOneself walking, can not move about, can only be attached to fixed on the rock in seabed and coral reef and grow, even near submarine volcano mouth,As plant, anchor at as you were, the seabed that reposes throughout the year, from flow through seawater at one's side, obtain food. Take a fancy to from appearanceGo, sponge extraordinary image plant, for this reason, in long time sponge to be mistaken as be a Plants of living in water always,Even some biologists also think like this. Because sponge can not be walked about, can not drift with the tide, or be fixed on rock in water,On shell, water plant or other object. Before 18th century, sponge is treated as plant always, afterwards due to microscopicalInvention, and animal embryology progress of research, people are familiar with the true features of sponge, have finally determined the real genus of spongeProperty: 1765 one make the biologist of Ai Lesi for the first time sponge be belonged to animal.
Sponge color is dazzled beautiful colorful, has cerise, silver gray, white etc., but lives in the sponge in seawater, and majority is ashThe block of yellow, brown or black. So, although sponge is called as " marine flower and fruit ", look general like plant,Be actually a kind of animal. So that sponge seems more to seem a feast for the eyes: under the searchlighting of light, some pictures are a stringLarge red lantern, more as unsurpassed in exquisiteness vase and cup small cup. This feature of sponge makes people's difficulty distinguish true features especially. UntilIn modern age, microscopical appearance, has just opened the mystery of the ownership of the sponge of arguement whole 2,000 years.
The Morphological Features of sponge has three:
(1) build is asymmetric
The build of sponge is varied, and little only several grams, large but has 45 kilograms. Spongia mostly is colony, monomerLess. Monomer health is radiation symmetric or asymmetric, generally makes pyramid, dish type, goblet shape, spherical etc. The profile of colonyAlter a great deal, shape and size differences are large, and shape is peculiar, in different poses and with different expressions, extraordinary-looking, cover shape to barrel-shaped and flower by very thin tableDoleiform not etc., does not have sheet, irregular bulk, ampuliform, tubulose, spherical shape, gyalectiform, fan-shaped and dendroid etc., numerous. ExampleAs Leucosolenia is the colony of flat tube shape, loquat sponge is as a round loquat, and short cypress sponge is like the lantern of a string exquisiteness, BuddhistSon is situated between as same glass fibre ball stands on handle, and hermit crab suberite is flat as thin paper, venu's-flower-baskets and is called as " dimensionReceive this gaily decorated basket ".
Due to environment difference of living in, condition is changeable, and the matrix type adhering to is different, and current power differs, and has therefore formedThe form that sponge is colourful. Most sponges live on the substrate of solid rock. The waters that ocean current is strong, the height of sponge is generalLess than 2.5 centimetres, and the surface of sponge forms many fairshaped lines, and this evolution can be avoided being rolled over by wave and ocean currentDisconnected. Some sponges are liked living in caves, and they get into the cave everywhere on the shell of abalone and oyster, under then living away from home on their shell.What is interesting is, the shape of sponge is normal similar with the set thing of sponge, is fixed on the sponge of coral or crust, and shape is just as coralOr crust. Conventionally the size of flow rate of water flow, the power of wave activity, the hard soft degree of substrate, also often makes the sea of same speciesSilk floss has different formalnesses, for example offshore surf zone life conventionally like wrapping on rock, like thin eggplant skin orGinger peel; Live in anxious environment at stream again mostly as knoll, have good streamlined build; And at unhurried current or right up and downPerch in environment, the bodily form again more is towering chimney-like.
The color of sponge is rich and varied equally. Their color is mainly in body, to have different types of marine alga symbiosis,Make them present different colors. The appearance of tubulose sponge resembles the chimney of setting very much, so be called again chimney sponge. Tubulose spongeHealth in have a lot of apertures. Water constantly flows through from aperture, and nutriment is wherein just by tubulose spongy absorbing. WithTime, the refuse that tubulose sponge produces also can be along with seawater flows away. Seawater flows in the body of sponge from the aperture that spreads all over sponge whole body.Each aperture leads to a cubicle, is called filter chamber. All filter chambers all lead in a chamber as bottle, this chamberBe called hole ante-chamber. The upper end in chamber is a very large apopore. The passage that the aperture of sponge enters as oxygen had both played breathingEffect, can absorb again the nutriment in water, and excretion refuse, can also discharge sperm and ovum, completes reproductive function.
(2) there is no clear and definite tissue and organ
Spongia is organized original, without real gastrovascular cavity and nervous system. Unique is simply the internal structure of sponge:Sponge is a kind of two germinal layers (not growing completely) animals, and whole health is made up of inside and outside two-layer cell, there is no the group of differentiation in bodyKnit, only some cell has difference in structure and function, and outer (cortex) is made up of flat cell and porocyte; Mesoglea is not haveThe cell of stratification, comprising calcareous, siliceous or keratose; Internal layer is made up of choana, is mainly trophic function, plays cellInterior digestion.
On sponge body wall, there are many apertures (claiming " blasthole "), therefore also claim " porifera ". Individual body image bottle, kettle, mortar etc., haveShi Liancheng colony. Most marine products, set life. There is macropore opening (claiming " delivery port ") free one end. Body wall is by inside and outside two-layerCellularity, okioplast is flat, the thin brain flaggellation of internal layer, most tool plasm necks, therefore claim " choana ", main row is ingestedEffect with intracellular digestion. Blasthole passes into the raceway groove in body, complicated with flagellated chamber and the delivery port composition of choana compositionChannel system. The seawater that contains bait, due to the continuous vibration of interior confluent monolayer cells flagellum, flows in body from blasthole, indigestibleThing flows out external with seawater from the delivery port on top. At inside and outside two-layer iuntercellular, also have one deck mesoglea, wherein resemble changeThe free cell of shape worm, reproduction cell, osteoblast, spongioblast etc. The needle-like that in spongia body wall, many tools are supportedSkeleton, claims spicule. In this animal, there is a few species can be for swabbing machine, firearms and press and shower; Some kind energyDestroying shell, is the harmful animal of shellfish culture.
Sponge can not be recognized from photograph, size, shape, distribution and arrangement that its main characteristic of division is that spiculeDeng. Between sponge two confluent monolayer cells, also has some special structures---spicule, just because of had structure like steelframe, just guarantorHold sponge and there are various forms. The textural very ingenious exquisiteness of spicule of sponge, meet the principle of mechanics, but this must pass throughElectron microscope just can be seen.
Bone has three kinds, the mineral matter of spicule (spicule), bone silk (spongin) and non-spicule type, and spicule can divide by sizeFor macrosclere and spiculum. Spicule composition is calcareous (calcite, aragonite) or siliceous (opal), and the composition of spongin is cutinOrganic compound, be thread, branch or handing-over together. Spicule and spongin: have archaeocyte, become sclerblast and Cheng HaiContinuous silk cell. Spongin is perishable, is difficult for forming fossil.
Though poriferous cell has the division of labor, cooperate with one another very micro-, as sponge is ground and sieved, what wherein separated is thinBorn of the same parents still can be survived a couple of days (being equivalent to protozoan). If but no longer combination each other just can not survive down, spongia thisPlant the i.e. independent feature of cooperating again, show that its organism structure still belongs to cell grade, has shown original metazoan feature.
(3) there is ditch property
The basic structure of spongia health is made up of around a cavity of central authorities two confluent monolayer cells. Free one endThere is a large delivery port (Osculum) that central chamber (CentralCavity) is communicated with the external world. Form spongia body wallTwo confluent monolayer cells in the different ditch of different species composition complexities system, according to ditch, system can be by poriferous body structureBe divided into three types.
1. ascon (AsconType) is the most original, is also the simplest body wall structure, and kind is little, and Leucosolenia justBelong to this class.
Ascon sponge is monomer or colony, and length is generally no more than 10cm, and the individual profile in colony is obvious, often each and every oneBody is all little tubulose, and delivery port has spicule to surround around, and central chamber is broad, and body wall has middle colloid by two confluent monolayer cells therebetween(Mesoglea) form, okioplast claims cortex (DermalEpithelium), is mainly by one deck pinacocyte(Pinacocytes) composition, it is different from the epidermal layer cells of other animals, because their source and other multicellular animalsEpidermal area difference, and this pinacocyte do not have basement membrane, the edge of cell can shrink. Many pinacocytes shrink simultaneouslyCan make health diminish. Some pinacocyte specializations forms tubulose, is called porocyte (Porocyte), intert pinacocyte itBetween. The outer end of porocyte communicates with the external world, and the inner communicates with central chamber, and the aperture of porocyte outer end is exactly ascon spongiaThe water inlet aperture (Ostia) of body surface or title ostium (IncurrentPore), so it is cell endoporus, water is entered by ostiumEnter central chamber. The contraction of porocyte and diastole can be controlled the influx of water. The internal layer of body wall also claims gastral layer (GastralEpithelium), be made up of neck flagellated cell (being also called for short choana), the choana of ascon sponge is round whole central authoritiesChamber. Choana is oval, and what its base portion was loose is seated in mesoglea, and free-end stretches out a flagellum, around the base of flagellumThere is a telescopic plasm neck in portion, is made up of the microvillus (Microvilli) of many separation. Sponge passes through asconThe swing of choana flagellum makes water be flowed into by porocyte (or claiming ostium incurrens), is flowed out through central chamber by delivery port again. ChoanaIn form, be very similar to the neck flagellate of protozoa, therefore someone thinks that spongia is by the evolution of neck flagellateCome. Between the cortex of body wall and gastral layer, be mesoglea, it is a kind of gluey residuite that contains protein, comprising there being tripFrom ameboid cell (Amoebocyte) and disperse spicule (Spicule). Ameboid cell can be divided into different forms, exampleIf any the elongated branch of ameboid cell pseudopodium, formation connected with each other is netted, is called asterism cell (Collencyte), someone thinksIt is the most original a kind of cell with nervous function. Another kind of cell is larger, and its nucleus is also larger, has lobopodia,Claim archaeocyte (Archeocyte), this is a kind of undifferentiated cell, engulfs and the function of digest food except itself havingOutward, it can also change into tool reproductive function reproduction cell (GenerativeCell), can secrete the osteoblast of bone(Scleroblast), the storage cell (Thesocyte) of stored nutrient material, the muciparous gland cell (Gland of energyCell) etc. The maximum feature of ascon spongia is that body wall structure is simple as can be seen from the above, the bag that its two confluent monolayer cells is straightEnclose central chamber. Because central chamber is broad, moving by the flagellum of choana the water velocity that makes to flow through health is slowly, and metabolismLow, so ascon spongia is all generally small-sized. Spongia has increased by the inverted pleat of body wall during evolutionThe quantity of choana and the surface area of distribution have reduced the volume of central chamber simultaneously, have consequently formed sycon or multiple ditchThe body wall of type, has so just accelerated water and has flow through the speed of health, has improved the ability of metabolism, makes the animal also increase volume.
2. sycon (SyconType) is the preliminary form of one of body wall inverted pleat, for example cup sponge (Scypha), sycon(Grantia) etc. The pinacocyte pleat of sycon spongy cortex, to mesoglea, forms multiple blind pipes that are arranged in parallel, and is called streamEnter pipe (incurrentcanal), the perforate ostium (incurrentpore) by name of inflow pipe outer end. The choana of gastral layerAlso form multiple blind pipes that are interspersed between inflow pipe by central chamber is outstanding outward, be called flagellum pipe (flagellatedOr flagellated chamber canal), also referred to as banj (radialcanal), its inner perforate is called apopyle (apopyle),Result inflow pipe and flagellum pipe have formed the body wall of sycon alternately. Between adjacent inflow pipe and flagellum pipe, also there is apertureTwo pipes are communicated, and this aperture claims prosopyle (prosopyle). Due to the appearance of pipeline, the body wall of sycon has been thickeied, alsoBecause choana pleat enters in flagellum pipe, on central chamber wall, no longer include choana, but surrounded by pinacocyte. Sycon spongeCurrent approach be: water → ostium → inflow pipe → prosopyle → flagellum pipe → apopyle → central chamber → delivery port →External. Sycon sponge has increased the area of choanosome, and the dwindling of the increase of pipeline and central chamber also accelerated current and passed throughThe speed of health. In sycon sponge, its cortical cell of some kind and mesoglea are more flourishing, so that have hidden whole body surface,Having formed the crust (cortex) that one deck or thin and thick differ, there is more ostium in result, can increase like this in body wallHydraulic pressure, accelerate water in vivo flow.
3. the complicated rhagon that just formed of the further inverted pleat of rhagon (leucontype) body wall, most seaContinuous animal belongs to this type, for example fresh water sponges. The change list of rhagon structure is following four aspects now:
(i) flagellum pipe continues to enter to mesoglea invaginate, so that has formed the flagellated chamber of multiple circles, for example thin bud sponge(Microciona) body wall of every square millimeter, flagellated chamber can reach 1,000;
(ii) mesoglea is more flourishing, and has formed numerous cortex hole (Dermalpore) or skin together with epidermal cellCavity of resorption (Subdermalspace);
(iii) inflow pipe is divided into many sprigs, and then enters flagellated chamber;
(iv) central chamber dwindles further, is finally replaced by the outlet pipe of branch (ExcurrentCanal). Multiple ditchThe current approach of type sponge is: water → cortex hole → cavus subdermalis → inflow pipe → prosopyle → flagellated chamber → apopyle → streamGo out pipe → delivery port → external. In some rhagon sponge, its forward and backward pylorus hole has extended to form forward and backward pyloric canal(Prosodus, Aphodus), structure is more complicated. Therefore rhagon spongia has larger choana surface area, in body, hasThe pipeline communicating in length and breadth, central chamber also further dwindles and has become tubulose, and the discharge of therefore flowing through in body increases, water flow velocityDegree is accelerated. The volume of rhagon sponge is all also relatively large, particularly in the large-scale sponge of colony, we only can from many go outForm and the size of sponge individuality judged at the mouth of a river, for example rock sponge (Reniera). The colony of fresh water sponges becomes bulk, veryDifficulty has been judged individual form.
3, classification
The kind of sponge is numerous, and modern sponge a few types in Demospongia belongs to fresh water sponges, most seasSilk floss is marine animal, lives in seabed always. Scientist estimates, approximately has 15,000 kinds of sponges to be distributed in each waters, the world, from shallowThe trace of the extra large sponge that grows on trees to the deep-sea of 8,000 meters: the tender calcisponge of modern rock-block field is distributed in sublittoral more, but glassGlass sponge can reach in the deep-sea of 6,000m deeply in perch, and fossil sponge also requires the similar depth of water substantially. Sponge is on different groundThe matter epoch often form reefs with stromatoporoids, bryozoan together with algae. Although found again so far kind more than 1,000 from 1994New sponge kind, but great majority do not confirm in detail and describe, and still have many new kinds also undiscovered, as for Hong KongSponge is seldom as research.
Each difference of poriferous color and luster, has the shades of colours such as bright red, bud green, brown Huang, milky white, purple, as flower oneSample beauty. Therefore, people believe that it is plant always, until 1825, along with leaning on microscopical invention and use, and physiologyThe work of and embryology aspects, scientist just determines that it is animal. In fact, poriferous color derives from phycobiontOr inactive storage pigment, for example green is because of the viridescent zoochlorellae of its parachorium, and redness, yellow, orange colour etc.That its existence can be produced shades of colour because cell contains fat-soluble carotene. On body wall due to it, there is many titleFor the aperture of " blasthole ", foamed plastics seemingly, so cry again porifera, be a class of minimum grade in multicellular animalsGroup.
Biology classification is upper, and spongia belongs to the primitive invertebrate of the animal kingdom, and whole health is by inside and outside two-layer thinBorn of the same parents' composition, the interior tissue that there is no differentiation of body, only some cell has difference in structure and function, and body surface has 4,000 hundred million aperturesCommunicating with body cavity, and supported by the contact of chiltern fibrous skeleton, just looks like the densely covered canalizations in thousands upon thousands networks of rivers.
Poritera (Porifera) is the general designation of about 5,000 kinds of original multicellular aquatic animals. Sponge is porousThe general designation of animal pupil thing, Poritera is divided: Calcispongea (Calcispongea), Hexactinellida, DemospongiaeAnd four outlines such as os osseum sponge guiding principle.
Be fresh water production except spongilla sp belongs to (Spongilla) approximately 20 kinds, be distributed in the intertidal zone to 8 of ocean, 500 meters(more than 28,000 feet) depths, battalion's set life. As a very original animal monoid, its embryonic development and other are multipleAnimal difference has reverse phenomenon in primitive gut forming process, thinks that according to the most scholar of these features spongia existsPosition in the animal kingdom isolates, and is that a metazoan side is propped up, and therefore also someone is referred to as Parazoa suberathem(Parazoa)。
Spongia is the minimum grade person in metazoa. The needle-like skeleton of many tools supporting function in spongia body wall,Claim spicule. According to the character of spicule, can divide calcisponge and the large class of non-calcisponge (Incalcarea) two.
In Porifera (Spongia) animal, there is a few species can be for swabbing machine, firearms and press and shower;Some kind can be destroyed shell, is the harmful animal of shellfish culture. Porifera comprises as follows:
1. Calcispongea (Calcarea), a guiding principle for Poritera, the spicule forming taking tool calcium carbonate is as main specialLevy. The whole marine products of calcisponge, live in littoral shallow sea mostly. Build is generally very little, is often lead or grey. Spicule topOutside normal excrescence, cause sponge to be thorn-like; Typical calcisponge is radiosymmetric ampuliform, and top is delivery port, is often erectedVertical long monaxon is around, title delivery port Tassel. Spicule is not of uniform size, but all can be regarded as macrosclere on taxology, has 3 kinds substantiallyType: monaxon, triactine and tetractine, shape is varied. Calcispongea is divided into Calcaronea and limeSponge subclass.
Calcispongea kind is many, has monomer, as sycon (Grantia); There is branch to become colony, as Leucosolenia(Leucosolenia) calcareous spicule has spicule, triradiata etc. The appearance of calcisponge in stratum is later than ordinary spongeAnd hexactinellid.
2. Hexactinellida (Hexactinellida), a guiding principle for Poritera. Major comonomer. Skeleton is all six to putTrichite (three axles respectively meet at a bit mutually with right angle) formed, i.e. the siliceous hexactine (being triaxon) of tool, sixSpoke is orthogonal to intersect at a point. The spicule of hexactinellid can be divided into macrosclere and spiculum. The hexactine of some kind is mutualHealing, forms fixing body wall bone mutually.
Originate in deep-sea, major part lives in 200~8, the seabed of 500 meters. Foremost as " venu's-flower-basketing "(Euplectella), for upper end is large, the slightly thin oval cage shape in lower end; Often there is paired shrimp (pari shrimp) to live wherein, " live together to a ripe old ageSame cave " one come therefrom. " stroking son is situated between " (Hyalonema) is and has the gaily decorated basket of lid shape, and lower end has a branch of elephant to stroke sub lengthGlass fiber, in order to be inserted in the silt of seabed.
In bone without spongioplasm. Cavernous body is often radiosymmetric ampuliform, column, gyalectiform or funnel-form; Tissue looseness, structureMake exquisiteness, have numerous species base portion to there is the spicule (claiming base palpus) of fibrous root shape, be directly inserted in globigerina. Hexactinellida dividesSix Astraeospongia orders and double plate sponge order. Hexactinellid, particularly six Astraeospongia orders are most important classes in fossil sponge. ?Early come across in Cambrian rock stratum, peak to the Cretaceous period and Jurassic Period.
3. Demospongiae (Demospongiae), a guiding principle of maximum in Poritera. Bone is siliceous and spongioplasm,In trichite, there is no 6 spoke spicules, but have dividing of size. Normal and the trichite of spongioplasm bone exists simultaneously.
Kind is a lot, and Gai Xi colony is block. Spicule is siliceous, borrows spongioplasm (a kind of thing of similar silk between pin and pinMatter) adhesion mutually; The spicule of some kind is wrapped in spongioplasm, and the spicule of other kinds all disappears, and only has spongeThe webbed skeleton of the crisscross intersection structure of fiber of matter. For example bath sponge (Euspongiaofficinalis) and horse sponge(Hippospongiaequina), bath sponge originates in Mediterranean, and the southern Chinese island of Hainan also produces. Mesh is thin, resilient beam, technique, doctorLearning and using all day needs.
This guiding principle kind accounts for the over half of sponge kind. Most marine products, are distributed in intertidal zone, shallow sea to deeply reaching 5000mSeabed; Also have a class to live in fresh water. The ditch system of ordinary sponge all belongs to rhagon, and cavernous body does not have central chamber. Lai WeiThis guiding principle is divided into 3 subclasses: Tetractinomorpha, horny sponge subclass and with bone sponge subclass. The bone that Spongiidae is various types ofFor pure spongioplasm structure, quality softness, is used to water suction, shampooing etc. for a long time. Mainly be distributed in Perenniporia martius shallow sea.
Fresh water sponges (Spongilla) massive colony, is yellow, brown, green isochrome. Spicule is little shaft-like. Except gemmation,Winter, some soma was concentrated a place, external double-layer films, and intermembranous respectively have the spicule of a shallow bid to support by two ends, formsSo-called " gemmule ", grows for ordinary colony spring again. Move in fresh water, be common on water plant branches and leaves and stone. KindClass is many.
Fine hair horse sponge (Hippospongialachne) belongs to Demospongiae (Demospongiae) net Keratosa(Dictyoceratida) angle bone Spongiidae (Spongiidae) sponge, is distributed in the regions such as marine site, South China Sea Xisha. FromIn this genus sponge, separate and obtain the multiple terpenoids such as terpenes quinones, furans terpenes, triterpene olefin(e) acid, but so far for seeing from thisBelong to the report that is separated to sesterterpenoids compound H ippolideJ in sponge.
4. os osseum sponge guiding principle (Sclerespongiae) a: guiding principle for Poritera. Mere formality stone matter or calcite matter spicule,The fibrous inner skeleton of trichite and spongioplasm. The cavernous body bulk of os osseum sponge, base portion has one deck to be slightly honeycombCalcareous (aragonite matter) bone, the size and shape of each chamber is slightly different. Above base portion bone, there is one layer of cells tissue, in tissueThere are siliceous needle and organic fiber shape bone; There is many volcanoes shape protuberance on sponge surface, and its top is circular delivery port, goes outWater pipe radially distributes in cell tissue from delivery port. Lower point of two orders of this guiding principle: star thorn sponge order and tabulare sponge order.
4, existence and breeding
The spongia a corner of always staying alone, just seldom there is other animal in the place of every spongia perch extremely lonelylyBefore go live. Scientist analyze reason that this phenomenon forms be first spongia to those voracious animals without any suctionGravitation, its spicule and fiber from head to foot makes other animal be difficult to swallow, and therefore poriferous natural enemy is few. Secondly, sponge is movingThing is perched mostly the mobile seabed of ocean current, and a lot of animal is all difficult to live in such environment. Because there, itLarva or washed away by current, or by spongia filter food. In addition, spongia has one unpleasant evil with it conventionallySmelly, this is also possible be that other animals are reluctant one of reason of associating with it.
The Individual Size of sponge differs greatly, little several millimeters, greatly tens meters. In the one of An Liesi archipelago lifeSpongia, shape is as a hollow vase, and 106 centimetres of heights are wide 91.5 centimetres; Neptune sponge is also the kind that the bodily form is largerClass, long 120 centimetres of section, but not too wide. The spongia of bodily form maximum is once to drag for one that obtains in Bahamas Islands in 1909,Enclosing length is 183 centimetres, and just water outlet weighs 40 kilograms, and the weight after drying is more than 5,000 gram. The heaviest sponge is as a large ball, the insideCan contain 100 premium on currency, the weight of these water is at least the more than 30 times of sponge. So sponge is just individual ghost in fact. Minimum kindClass is Leucosolenia, only 3 millimeters of heights, and body weight only has several grams, equally little with a sesame.
Little sponge approximately can live 1 year, and the large life-span is longer, and some kinds allegedly can be lived the centuries. Marine sponge 7 yearsHou just reaches size for commodity, and the life-span may reach 20 years.
(1) predation and symbiosis
How does spongia obtain food? its predation method is very peculiar, is by a kind of filter food mode. MonomerSponge is the spitting image of a vase, and each aperture on bottle wall is one " face ". Spongia passes through constantly vibration body wallFlagellum, makes the seawater that contains bait constantly infiltrate bottle chamber from these apertures, enters in body. There is countless neck flagellums at " bottle " inwallCell, is fluctuateed to top spirally by base portion, thereby produces unidirectional gravitation, plays the pump of similar water pumper and inhales workWith. In the time that seawater infiltrates from bottle wall, the nutriment in water, as animals and plants chip, algae, bacterium etc., just by neck flagellated cellAfter seizure, engulf. Through digesting and assimilating, those indigestible things flow out external with seawater from delivery port. If graphite powder orSeveral melted inks drop in the poriferous side of work of raising in aquarium, do not cross how long bottleneck (apopore) is located to flow outThe thread of black. Along with current endlessly, bacterium, diatom, protozoan or organic debris are also brought in body as neck is thinBorn of the same parents capture and are made for nutrition. This foraging pattern has fully proved that it belongs to the heterotrophism animal of filter food.
Most of sponges are all attached to his thing, as rock face, or on a solid object in silt, anchor at other biologicalTime, make sometimes these biologies (as barnacle) death. Sometimes the biology of sponge and institute's set is mutuality of interest, on hermit crab shellSuberite (Suberitesdomuncula) by hermit crab with mobile, and the smell of sponge is kept out of the way fish and other animals.In the surface of sponge or water pipe and chamber, also have various animals and plants life work, that sometimes in a sponge, lives has several thousand lifesThing. Sponge is liked and other biocenosis commensalism. Some animal and sponge are set up extraordinary symbiosis or parasitism, haveSponge just becomes the inhabitation place of hermit crab, and some algae is long makes its whole body become green on the body of sponge, at first glanceIt similarly is a beautiful algae. Some ghost crab is liked that sponge is torn into fragment and is attached on leg or shell, allows sponge on their bodyGrowth is got up, and like putting on the thick armor of one deck, ghost crab is defendd harmful animal with this. Sponge is often fixed wtih at whelk or oyster shellUpper, oyster and whelk are willing, because sponge can secrete niff with it, help them to draw back harmful animal with fear. This is also seaOcean biologist can be in can the move about reason of sponge of seabed discovery.
In the commensal of porifera, the most important thing is unicellular or many cells algae. Sponge provides protection and generation to algaeThank to refuse, and algae is supplied with sponge oxygen, the dead Hou of algae also can be used as the food of sponge. Some animals colonize in sponge body surface orIn body, if cyclops is the most important parasite of marine products sponge. Wheel animalcule colonize in fresh water sponges body , Shui ?lay eggs therein,Shui Ling section (Sisyridae) larva lives in fresh water sponges body and taking sponge as food. In general, carnivore does not eat seaSilk floss because sponge the smell is awful, have os osseum pin. But some shellfishes (chiton, limpet), shell-fish and fish are taking sponge as food.
The young that pari shrimp belongs to (Spongicola) can enter in some sponge, and growth Hou is lived and wherein can not be swum in couplesGo out the symbol that Japanese is considered as these shrimps to live a long life together. Why Here it is finds sometimes a pair of work in the body of spongeThe reason of shrimp. This is some paired male and female shrimps, and they creep in the body of sponge and live, grow up and just can't get out," be stranded " inside, until old dead. Their nutriment of sponge supply, shrimp is cleared up the dirt in duct in cavernous body, twoSide's mutual reciprocity and mutual benefit, harmonious coexistence. This phenomenon is biologically referred to as " venu's-flower-basketing " (Venus ' sflowerbasket). AndPaired shrimp in cavernous body, this owing to living " cage " life, lives a long life together, and will never change until death, and becomes resembling of loyal and steadfast loveLevy. Japanese often gives married couple them as wedding present, and shrimp is beautiful its " pari shrimp " by name also.
(2) filter food is with energy-conservation
The swing of flagellum will be consumed energy. Concerning the spongia of battalion's set life, from food, obtain chemical energyBeing difficult for. Therefore, spongia always lives in the seabed of ocean current process, in the evolutionary process of millions upon millions of years, perfectA set of ability of utilizing the natural fluid energy of flow, thus valuable food chemistry energy saved. One high 10 centimetres, 1 li of diameterThe sponge of rice, can take out 22.5 liters, seawater in one day, the water velocity of water outlet can reach 5 meter per seconds. The current that this high speed is left awayEnsure no longer " to melt down " from waste from bodies of animals. Spongia has had filter food and energy-conservation ability just, could lackIn the tropical coral reef of nutrition and shelf area, polar region is procreation from generation to generation. Sponge is the filter feeder of set. One end when sponge lifeSet, the other end is free, i.e. numerous projections of sponge body surface, there are many apertures (blasthole) on the side of projection, common projectionThere is a macropore (apopore) on top. Sponge is covered with the ring of having many flagellums and a sieve-like in the aperture of whole body,Seawater is taken in the swing of available whip, and seawater is brought oxygen, bacterium, small algae and other organic debris into, and seawater just flows from apertureEnter, to the pipeline that is abound with tail cell (being choana) in body; Along with the rhythmical swing of choana afterbody, seawater is again through ringShape thing filters, and flows out again from macropore; Water ceaselessly flows in cavernous body from the hole of flat cell, then flows out from apopore,Take a fancy to just as a water pump, had no life. Meanwhile, those small biologies are along with current enter in cavernous body, in seaFood particle and oxygen in water can be filtered out, and remaining part can be discharged from apopore, finally become sponge dimension meterThe food of existence " hauling oneself willingly into the net ".
Body surface and inner-walls of duct in sponge have pinacocyte. Also fenestrated cell of the appearance of calcisponge class, above has into waterAperture, when environment is bad, porocyte shrinks and closes aperture. In mesoglea, also has collencyte, in order to eccrine fiber. Hat is thinOne end of born of the same parents has a microscler cytoplasm prominent, thereby is similar to comet outward, can secrete the skeletogenous spongioplasm of shape. Osteocyte produces boneMatter, forms spicule, can be divided into again calcareous osteocyte and silicon matter osteocyte. Myocyte is microscler, can shrink, at most other at delivery port,Can control its switching. Bone is the important evidence of sponge classification, has plenty of inanimate matter, as calcareous and silicon matter spicule, have byProtein becomes to be grouped into other, as spongin. Spicule scatters in vivo or is linked to be fiber, rises and supports and protective effect. PorousAnimal is filtered and takes food, and seizes the food grain in water in suspension by choana, is mainly bacterium, organic debris, also may absorb dissolvingOrganic matter. In ocean, have hundreds of thousands kind sponge all day water inspiration to be gone to spue again and come, they extract food from water with this. ByOn choana, the swing of flagellum, causes current. Direct exchanging gas between tissue and water. Refuse is through delivery port and body surface rowLet out. The sponge seawater that filters its volume three to four-fold per minute, every day is quite surprising by the water yield of its health, and one is straightThe sponge that footpath is only 1 centimetre, high 10 centimetres approximately has 2,250,000 flagellated chambers, within one day, can filter 20 kilograms of seawater; Large sponge can reachTon water, sponge but only can therefrom absorb pitiably little food.
(3) reproduction and growth
Poriferous reproduction is asexual reproduction and two kinds of modes of zoogamy.
1. asexual reproduction
Asexual reproduction is taking gemmation as main, mostly occurs in marine products kind. When environment is around not suitable for sponge lifeWhile depositing, sponge will produce gemma, because gemma outside has thick film can resist the impact of external environment condition, makes them passableSurvival for a long time, after surrounding environment is improved, gemma develops into little sponge again.
Parent's ameboid cell while sprouting, the top end surface that particularly some archaeocytes move to parent by mesoglea is assembledAgglomerating, then develop into little sprout, be shed to subsequently bottom and develop into new sponge, or be connected to form colony with parent. Fresh waterSponge and minority marine products kind can form gemmule (gemmule) under certain condition, are also considered to a kind of asexual reproduction, individualArchaeocyte in body ingested assemble after a large amount of materials agglomerating, surrounded one deck osteoblast. Outside original cell pelletSecrete voluntarily layer protecting film, its constituent class is similar to spongin, to protect inner gemmule cell, and osteoblast secretion afterwardsThe spicule of layer double plate shape or needle-like, makes gemmule have the ability of very strong opposing adverse circumstances. A spongia can formMany gemmules. In the time that external condition is suitable, the cell in gemmule discharges by micropore (micropyle), then shape laterBecome a new individuality. The gemmule outside of marine products kind is surrounded by spongin, has or do not have spicule. Not tool of the gemmule of a few speciesThere is spongin.
Poriferous regeneration is also considered to a kind of asexual reproduction, and the sponge of numerous species has very strong Regenerated energyPower, for example Leucosolenia, its health fragment is only greater than 0.4mm, and with some choanas, just one new of energy regenerationBody, this is because poriferous cell has stronger polymerizing power and recognition capability. Also there is people by poriferous healthWith mechanical means crushing, by cell separation, then use filtered through gauze, the cell dispersion in its filtrate is put into seawater again and is cultivated, knotThe cell polymerization again that fruit separates, and move to respectively on correct position, one or several new individuality finally formed. AlsoHaving a classical experiment is to be undertaken by Galtsoff (1925), and he tests with two kinds of sponges that do not belong to together, a kind ofThin bud sponge (Microciona), its cell tool haematochrome; Another kind is Haliclona, tool uranidin in its cell, and he willTwo kinds of sponge mixing with cells that are separated in advance suspension together, originally two kinds of random polymerizations of cell, but very fast two kinds of cells are pressedPlant and be separated from each other, form respectively red cell mass and chloragogen cell group, the cell masses different with latter two break up separately, last shapeBecome two kinds of thin bud sponge (erythrocyte) and Haliclona (xantholeucophore) new individual. Also find many fresh water sea laterThe sponge of silk floss and marine products has this characteristic. There is afterwards people to confirm the sugared egg of a kind of macromolecule of sponge cell surface with experimentBe the identification molecule of sponge cell in vain, it has the specificity of planting, so cell energy polymerization of the same race, cell not of the same race divides mutuallyFrom. Homocellular polymerizing power makes it can regenerate and form new individuality.
Why sponge has huge and prosperous family, should give the credit to that peculiar and extremely strong power of regeneration, can not onlyRecover part impaired or that lose, and can be from an even neosome of individual cells formation of fragment. The regeneration of starfish and sea cucumberAbility is very strong, but compared with sponge, can be exactly to have felt dwarfed. In the time that environment is unfavorable, sponge becomes fractionlet, byArchaeocyte of pinacocyte outsourcing forms; When condition takes a turn for the better, then grow up to sponge. Because not having central authorities, sponge regulates organ(brain), cells in vivo can move again, so be difficult to discriminate individuals and colony, can only say every by a common ectoderm wrappingIt is exactly body one by one.
Someone tears sponge to throw in the sea of faces to bits, sponge can also one piece independently grow up to complete newly individual one by oneBody. Orange sponge is smashed into pieces to cell suspension with Huanghai Sea brocade and mix, can find that two kinds of sponges are by kind weight separatelyNew arrangement and polymerization, forms new orange sponge and Huanghai Sea silk floss. If the sponge of smashing to pieces is put and examined under a microscope, can seeThree or five, sponge cell bunches up, and just becomes soon new cavernous body one by one.
Compared with other invertebrates, the structure of sponge is simpler, there is no the organs such as heart, brain, head, mouth, only by manyPlant cell aggregation and formed together inside and outside two layers of body wall. Outer layer body parietal cell is divided two kinds, flat cell and garland cells. Ring is thinBorn of the same parents one end have a circle tiny, be bar-shaped cilium, wherein long have one long like the same flagellum of whip, cell can be ceaselesslyBrandish flagellum, by constantly inspiration of water with eject, the bacterium in water, tiny organism are bonded on flagellum as oneself simultaneouslyFood. Flat cell has many holes, and water flows in cavernous body by hole, and therefore sponge is also referred to as " porous " animal. SpongeInterior confluent monolayer cells can be out of shape and migration everywhere in cavernous body, can also become the cell of other kinds, as outer field garland cells, flatThe reproduction cell of flat-shaped cell and generation sperm and ovum. Express one's surprise, wonder, etc most, interior confluent monolayer cells becomes after other cells, can also become againReturn, this cell is called " totipotent cell " by scientist, and this is also why sponge can also grow newly after broken againThe reason place of sponge.
The gemmule of a kind of fresh water sponges that Spongia belongs to has diaphragm outward, and has spicule to reinforce. When environment takes a turn for the better, former thinBorn of the same parents overflow from aperture, are divided into different cells and grow up to new individuality. Other asexual reproduction are as formed stolon or individual fracture.
In order to resist natural enemy, not by the animal predation such as fish, green turtle, sponge also has the safeguard measure of oneself, some sponge meetingsProduce very niff, other biological is shied away; Some meetings are outside exposed by spicule, and predator dare not be acted rashlyRecklessly act; A kind of material that is similar to venom of some meeting secretions, this is the mean of defense of sponge, in order to strike back harmful animal, or kills weekEnclose the poisonous microorganism in seawater, make surrounding's seawater of sponge life become cleaner.
2. generative propagation
Except tetractinellia (Tetractinellida), spongia all can be manageed it zoogamy. Most of kinds areHermaphroditic (hermaphordite), but sperm and ovum are often in the same period ripe, can be in same internal fertilization, butAlso can between allosome, carry out mating. Embryonated egg first develops into larva in cavernous body, then leaves parent floating with currentDevelop into little sponge to surrounding. A few species is gonochorism (dioecism). Reproduction cell is by the archaeocyte shape in mesogleaOne-tenth, choana also can lose flagellum and plasm neck and become spermatogonium (spermatogonia) sometimes, then division formsSperm. After spermioteleosis, excrete with current, and enter other individual flagellated chambers with current. It was observed some torrid zoneThe paroxysmal release sperm of sponge energy in area, in seawater, forms a milky nebulous sperm band, and its length canReach 2~3 meters. A sponge has discharged sperm and often can also discharge sperm by inducing peripheral sponge. The sperm discharging enters with currentAfter other individual flagellated chambers, then enter choana. At this moment choana loses neck and flagellum, carrying sperm to mesoglea andOvum fusion forms embryonated egg. Most of poriferous embryonated eggs are to grow in vivo. Some poriferous embryonic developments byIn the reverse of germinal layer and there is very large particularity, the sponge embryo development procedure of different guiding principles is also not quite similar, and this is mainly manifested inSpongia can form two kinds of dissimilar larvas. In calcisponge, form the amphiblastula of hollow(amphiblastula), in Demospongiae, form solid parenchymula larva (parenchymula).
Calcisponge, the embryonated egg of for example Leucosolenia or sycon is grown in the mesoglea of parent, when embryonated egg is through thinBorn of the same parents divide while forming 16 cells, and what form animal pole is 8 cellules, and what form plant pole is 8 maxicells. Animal poleCellule division is rapider, after splitting into the cell of some, has formed one and has had blastocelic blastaea, celluleAll grow a flagellum towards blastocelic one end, the outward opening of later cellule through between maxicell routed up, result celluleFlagellum move on to surface, formed one end amphitrichous, the atrichous amphiblastula in one end. Amphiblastula leaves mother with currentBody, swims in the water after a period of time through the caving in or Magnocellular outsourcing of cellule, or the associating of two kinds of methods and shapeBecome the primitive gut shape of two confluent monolayer cells, and anchored at bottom. Originally the flagellatus cellule of animal pole has formed the stomach of adultLayer (choanosome), originally the maxicell of plant pole has formed the cortex (pinacocyte layer) of adult, more common by two confluent monolayer cellsForm mesoglea and ameboid cell. Poriferous this Cell Differentiation and layering, with every other metazoan germinal layerDifferentiation is different. In other metazoas except spongia, the cellule of animal pole develops into the skin of adult (Germinal layer), plant pole maxicell develops into internal layer (being entoderm). This animal pole of calcisponge animal and plant pole cell phaseAnti-differentiating phenomenon is called reverse phenomenon (inversion), and therefore its two confluent monolayer cells are not called ectoderm and entoderm, and divideAnother name is cortex and gastral layer. Developmental reverse phenomenon is one of reason of spongia being classified as Parazoa.
Particularly rhagon sponge also recurrence through a primitive stage in growth in calcisponge, warp in growingSpend olynthus (Olynthus) stage of an ascon, then after stage of development through a sycon, finally just formThe adult of one rhagon. During most of hexactinellids and ordinary sponge grow through a parenchymula larva, the appearance of parenchymula larvaFace is flagellatus cellule except rear end, and later flagellatus okioplast moves into inner, forms gastral layer, inner distortionCell moves on to outside and forms cortex. In Demospongiae, many rhagon kinds, when growth directly from a rhagon larva(rhagon), this larva has broad base portion, narrow and small top, very large spongocoel, very little flagellated chamber, through body wallAfter inverted pleat, develop into rhagon adult.
Sponge does not possess the organ of carrying out various functions. Its most important structure is hydraulic pipeline, mainly by blasthole, neck carefullyBorn of the same parents and delivery port composition. According to the development degree of the arrangement mode of choana and water pipe, ditch is from simple to complexity, can be divided intoAscon, sycon and 3 basic models of rhagon. Without significantly organizing, body surface and inner chamber respectively have one layer of cells; Centre is middle glueLayer, is gluey, inside has other cells and fiber. Single ditch is the internal layer of sponge, is made up of choana amphitrichous, flagellum choanaThe neck that has a circle to be formed by cytoplasm around. The major function of choana is to cause current, and catches food grain. In mesogleaArchaeocyte, claims again ameboid cell, contains a large amount of ribonucleic acid in cytoplasm; The food of choana picked-up can be delivered to health eachPortion; Can develop into again various kinds of cell, in regeneration, work; Can generate if desired female, male sex-cell. But Calcispongea(Calcispongiae) reproduction cell (especially male sex-cell) is become by choana.
, sometimes on same individuality, there is sex reversal in the general hermaphroditic of sponge. Fertilization mode is special, sperm disengage Hou withWater flows in another sponge, is seized by choana, and choana becomes ameboid cell, and sperm is delivered to ovum place. Embryonic development hasDifferent approach, the pattern of result larva is incessantly a kind of. Calcispongea and some Demospongiae (Demospongiae)Larva claims amphiblastula. Demospongiae accounts for 80% of whole sponge kinds, and common larva is middle real larva. Larva swimmingA few hours, to a couple of days Hou, are found suitable place set, grow up to new individuality through metamorphosis. Asexual reproduction mode has several, gemmuleReproduction, is gathered and is formed gemmule by cell (being mainly archaeocyte). In some marine products kind, this is a kind of normal reproductionMode, sometimes as spending a kind of means of poor environment.
5, research and development
1. Evolution History
The ancestors of the mankind and all animals are the sponges that lived at least on earth 500,000,000 years, and the ancestors of sponge unexpectedlyIt is fungi!
Today, most of biologists believe that tellurian life originates from the very simple biology of one the earliest, stillWhat does is this simple ancient biology on earth? there is there what relation with the human and animal of today? but do not find for a long timeAnswer. But, under the subsidy of NIH and Nasa, U.S.'s microbial evolution is learned expert meter QieEr Suojin (MichellSogin) uses automated DNA permutation technology and computer program, is finding recently this problemAn answer: the ancestors of the mankind and all animals are the sponges that lived at least on earth 500,000,000 years, and the ancestors of sponge are fungies!Suo Jin says, understands animal and how to evolve, highly significant---not only can help us to understand future of life and will occur assortedChange, even can help us to understand the possibility that other life exist in universe.
Violent, susceptible, active---not " silk floss " of personality of sponge
Suo Jin had first understood sponge before understanding fungi.
In ocean on earth, have 9,000 kinds of sponges at least. Some sponges even live in fresh water. They are by bodyOn aperture, from tons of seawater, be filled into several grams of meagre nutriments and sustain life. Sponge is many cells(multicellular) biology, although some sponge has the bone that glass is the same. But on the whole, sponge is not organized, fleshMeat, organ, nerve, these important documents of brain.
The main component of sponge cell is calcium carbonate or carbonic acid silicon and a large amount of collagens. On the tube wall of sponge, longHave the long palpus (cilia) of swing, long palpus can filter refuse from seawater, leaves nutrition. No matter the volume of sponge is much, requiredAs long as food to meet each cell just much of that, not greedy. Certainly, in sponge, also there is " ferociousness " person. Raw in HawaiiLong sea of fire silk floss can be secreted venom, causes severe pain to other animal; Be grown in Mediterranean a kind of sponge, possess trick littleThe ability of shellfish, can stretch out sharp thorn they are surrounded completely, makes a hearty meal.
Sponge is also generative propagation biology the earliest, and most sponge is all hermaphroditic, can produce ovum simultaneouslySon and sperm also enter in water. Sperm can be roamed always in seawater, until find the reception entrance of another sponge pipeline.
The susceptible of sponge also shows: if it also has another mode of reproduction---a sponge suffers external force brokenBad, the cell of having been broken can be found companion in seawater, then again gets together, copy out one with their father and mother generation phasesSame sponge. After sponge is injured, can not replace the mode healing of wound of old cell with new cell, arrive but transfer old cellSite of injury, stops wound further to spread.
Like this, sponge very chicly lives under water, and provides sanctuary for thousands of kind biologies around. In addition,Sponge is in fact fine moving. Biologist Ka Er sweat Bond (CalhounBond) of North Carolina university in 1986Just find, sponge is not actionless, and he observes by precision instrument, and the edge of sponge can help as limbsOneself is mobile, and what have can move 4 millimeters for one day, and what have can climb up glass container wall unexpectedly.
From 1,500,000/probability, look for answer---gene divides exploring to look for a needle in a haystack
In the past, scientist judged that the contact between animal mainly depends on observation animal appearance, comprised that fossil judges. AsTwo kinds of biologies of fruit have common feature, such as claw, will be considered to have certain kinship. Along with dashing forward of gene technologyFly, utilize genetic analysis to find biological origin and started practical application. The seventies in last century, the tutor Ka Erwu of Suo JinYi Si (CarlWoese) has just started the research of this respect. Within 1989, Suo Jin has set up laboratory, and the problem of taking over tutor continuesContinuous research. Suo Jin concentrates on research direction evolution and the parasite aspect of gene, and he wishes that answer is led by these researchThe problem that teacher proposes: the most important unit of life, how cell forms.
Genetic analysis is not that some biological full gene of comparison forms, but by comparing some biological total baseBecause of section, analyze difference wherein and judge relation between the two, if both have similar sequence in the gene, and with equallyGene expression characteristics, so just can there are same ancestors by two kinds of biologies of inference. If gene order is very different, just canKnow they a long time ago with regard to bifurcated, evolved towards different directions.
Suo Jin wishes under this theoretical direction, adopts rRNA means, sets up an objective zoogeny structureEquation, he starts with from the gene order of very rare ancient bacterium (archaea), from planktonic organism, fungi, sponge, jellyfish, seaIn certain herbaceous plants with big flowers, mollusk, extract DNA, relatively their sequence in the gene order, relatively rRNA, and application decade countMethod, calculates the relation between they and insect, fish, birds, mammal.
Before two more than ten years, gene technology is also at the early-stage, and such planning is very farsighted at that time. In 20 generationDiscipline early eighties, scientist determines that a gene of tedemia ignis will consume year, all work are allManual operations. After several years, they can be in 10~15 factors of 1 year inner analysis. Today, Suo Jin can do overnight1,000 factorial analysis. Even if but today, it is right that one section of specific genome also may comprise 3,000,000,000 pairs of bases,Find out the relation of 2,000 pairs, probability is 1,500,000/, therefore, find answer similarly is still to look for a needle in a haystack.
2. previous and present life
Suo Jin has looked through the most ancient all biology, after the gene of jellyfish, sea anemone, sponge, mollusk, starfish etc.,Finally reach a conclusion: sponge is certainly the most direct ancestors of all animals today. Before Suo Jin, some biologist bosomsDoubtful sponge is actually a Plants, and other biologists suspect that sponge is the one life being independent of outside zoogeny chainThing, and the evolution result of today does not contact.
His discovery also shows, " younger generation " after sponge is trichocyst animal (cnidarians) class, such as jellyfish,Sea anemone, coral etc., they are the same with sponge has the bag-shaped bodily form, and they all have feeler, and have at the end of feelerThe mouth opening as face. But the cell shape of sponge has the feature of annular cell, it with very little long must, thisA littlely surrounded by less (hair shape) microvillus of a group again. Thousands of must ceaselessly brandishing in water, by freshSeawater is sent into " in mouthful ".
Suo Jin believes that the most direct ancestors of sponge are choanoflagellates, and choanoflagellate is also the biology of individual cells, has long whip oneThe palpus of sample, and surround must be a series of microvillus. Some in the middle of them are even leaned on to such an extent that very closely formed group, almostSoon develop into animal.
Although what the sponge being unable to find out today is the earliest, at least still possesses some of sea todayContinuous feature, today, we can find that diatom, these animals of horse crab are all about the same with their evolution appearance before.
All animals are all from fungi
The prior discovery of Suo Jin is that, on evolution coordinate, the ancestors more Zao than choanoflagellate are fungies, sponge and allAnimal comprises that the mankind are from fungi. Before this, a lot of scientists range plant mistakenly by fungi. But Suo Jin'sResearch discovery, plant and fungi are diverse two class biologies. Fungi and animal are the earliest from same family, and this point is notOnly understanding life source is had to meaning, understanding fungi is had more to realistic meaning to the invasion of human body.
Suo Jin says, the disease that fungi causes comprises ringworm, athlete's foot, myocarditis. Why difficult the disease that fungi causes isControlling is because fungi and the mankind have a lot of common ground, only has two kinds of biologies of working as to have different features, same what treat in other wordsWhen time does not injure main body, it is just easier to treat, this point, and believing can be to biomedical research enlightenment in the future. In addition, annualThousands of AIDS patients is died from cassette pneumocystis carinii pneumonia. Up to date, a lot of people also believe that this is one and malariaRelevant parasitic protozoa causes, but the recent findings of Suo Jin research group, and it is a kind of that cassette pneumocystis carinii pneumonia is actuallyThe biology close with fungi cast, uses and just can effectively suppress cassette pneumocystis carinii pneumonia to antimycotic medicine.
Suo Jin says, after sponge and trichocyst animal, has just occurred the biology of this both sides of insect symmetry, after this, rawThere is once volatile evolution revolution in thing, from then on, biological autotelic mobility is strengthened greatly, has possessed in the past anyBiological unexistent superiority.
3. purposes
Greeks, roman and ancient Chinese working people are familiar with and the animal that sponges very early, particularly batheWith sponge, mesh is thin, resilient beam, good water absorption, can be for operated bathing body cleaning, wash the dishes etc., afterwards again in technique, medical science and dailyLife aspect has represented increasing extensive use, as does paint brush, as liner and other mats of steel helmet, incineratesCan treat pin pain etc. In Mediterranean, Red sea and the ground such as America is coastal, the animal industry that carries the artificial cultivation of sponges is very flourishing, people are by seaSilk floss cuts into piece, ties up on frame with rope, drops into marinely, within 2~3 years, just can gather in the crops large quantities of sponges. But, along with artificial sponge's industryDevelopment, made spongia aquaculture decline increasingly. But along with scientific and technical development, people have found againThe value that spongia is new, for example, have people studying to use sponge purifying sea water, maintains the marine environment ecological balance to reachObject.
At present, sponge is to find the abundantest marine organisms of marine active substance, has become the weight of marine drug exploitationWant resource. In addition, American scientist represents recently, and they have confirmed a kind of dark abyssal cavernous body that is grown inCan produce fine glass fibre, this fiber can at least transmit luminous energy as the fiber optic cables of communication industry use.The glass fibre of this natural generation also more has pliability than made fiber optic cables. This cavernous body is grown in the torrid zoneDepths, seabed, it is high approximately 1 foot half, with a complicated silicon web frame, glass fibre forms one in the bottom of cavernous bodyIndividual crown. About 2~7 inches long of fiber, every almost thick with human hair.
Because sponge has the ability of degraded seawater pollution thing, also show the using value at marine pollution aspect. CloselyNian Lai, has had scientist to propose the concept of " spongy biological technology ". Can predict, sponge is at marine drug, marine organisms materialIn material, marine environmental protection, will bring into play significant role.
4. raise
Raise difficulty: because of after seizure and fishmonger's deal with improperly, or do not have enough food to provide, thus raise difficult,In cylinder, be difficult to permanent raising.
Temperature: 22~28 DEG C
Current: in to slightly strong current
Luminosity: most sponge does not have phycobiont, does not require (but to be placed on high light place, likely to cause that tongue is raw to illuminationBe longer than on sponge, be applicable to so be placed on dark bit comparison. )
Food: must feed and raise. Can feed the food that swims.
Remarks: process when sponge, sponge can not leaving water, otherwise the pipeline of feed in sponge can be hindered by airPlug, causes the sponge phytoplankton of can not taking food, then just can be slowly dead.
5. exploitation
It is not only the most original ancestors of animal because of them that scientist makes earnest efforts the research of sponge, and wishes by themEcology to whole ocean is studied. Since the middle of last century scientific research personnel finds there are many active biomass in sponge, can killAfter dead various harmful bacteria and virus, the people who is engaged in the world sponge research is more and more. But, Chinese Academy of Sciences's ocean researchThe people who does ocean means of taxonomic research in the scientific research institutions of Suo Deng ocean is almost the old scientist that whole-colored silver hair is grey, and youngResearcher but can not see, especially spongia means of taxonomic research leaves no successor especially.
Spongia is the most original, minimum etc. a kind of multicellular animals, not only extraordinary-looking, and has extraordinary regenerationAbility. Sponge can not only be used for daily life, and because it contains natural antibiotics, can kill tubercle bacillus, can be peopleTreatment rheumatism and the nervous system disease. In addition, sponge can secrete a kind of material that is similar to venom, in order to strike back harmful animal or to killThe poisonous microorganism in seawater around, scientist also finds that this toxin in cavernous body can be used for pharmacy, treatment tumour, the heartThe disease such as blood vessel and respiratory system. More make people joyful, have multiple cancer-resisting substance in cavernous body, some is extracted, just wideGeneral be applied to clinical.
Before three more than ten years, it is found that in cavernous body and have many special chemical substances, can be used as the raw material of medicine, cureSome difficult diseases, up to the present, people have found various active material in sponge kind animal body, can kill multiple thinBacterium with virus, so it attracts much attention again in recent years, will for people roughly the same disease, especially wage a struggle and do with cancerGo out contribution.
There is recently report, in the sponge of deep-sea, find anti-malarial material (Chinese golden medicine net). France developmental research scienceFamily announces recently, has found antimalarial material in the natural sponge at deep-sea, New Caledonia. In addition, according to French developmental researchResearch report, in wide vast living marine resources, deeply hiding in a large number virus, bacterium or cancer cell has inhibitionThe natural materials of function and cell protein. And at present the mankind are for understanding, research and the chemical analysis of these natural precious deposits alsoLess than 1%.
(2) extraction separation method of conventional Chinese medicine active ingredient
1, solvent extraction method
(1) principle: solvent extraction method is that it is right to select according to the dissolution properties of various chemical compositions in solvent in Chinese herbal medicineActive component solubility is large, to not needing the little solvent of composition solubility of stripping, active ingredient is dissolved in medicinal material tissueMethod out. In the time that solvent is added in herbal raw material (need suitably pulverize), solvent is because diffusion, osmosis are passed through graduallyCell membrane penetrates in cell, has dissolved solable matter, and causes the concentration difference inside and outside cell, so intracellular concentrated solutionConstantly, to external diffusion, solvent constantly enters again in medicinal material histocyte, so repeatedly comes and goes, until the inside and outside solution concentration of cell reachesDuring to dynamic equilibrium, this saturated solution is leached, continue repeatedly to add novel solvent, just needed composition can be bordering on completelyStripping or the stripping of large portion. The solubility of medicinal herb components in solvent is directly relevant with solvent property. Solvent can be divided into hydrophilyOrganic solvent and lipophilicity organic solvent, dissolved material also has hydrophily and lipophilic difference. Organic compound molecule knotIn structure, hydrophilic radical is many, and its polarity is negligent of greatly oil; Some hydrophilic radicals are few, and its polarity is little and be negligent of water. Each kind solventCharacter, equally also relevant with its molecular structure. Like this, inventor just can, by medicinal herb components structural analysis, go to estimateCount their this type of character and the solvent of selecting. Generally speaking, as long as the hydrophily of medicinal herb components and lipophilicity and solventThis character is suitable, will have therein larger solubility, i.e. the rule of so-called " similar mixing ". This is to select appropriate solventIn Chinese herbal medicine, extract required composition according to one of.
(2) selection of solvent: using the key of solvent extraction method, is to select suitable solvent. Solvent is selected suitably, just canMore successfully the composition of needs is extracted. Selective solvent will be noted following 3 points: 1. solvent dissolves active ingredientDegree is large, little to impurity solubility; 2. solvent can not play chemical change with the composition of Chinese medicine; 3. solvent is wanted economical, is easy to get, uses peaceCongruence. Common extraction solvent can be divided into following three classes:
1. water: water is a kind of strong polar solvent. Hydrophilic composition in Chinese herbal medicine, as inorganic salts, carbohydrate, molecule not tooLarge polysaccharide, tannin, amino acid, protein, acylate, alkaloid salt and glycoside etc. can by water-soluble go out. In order to increaseThe solubility of some composition, also often adopts sour water and buck as extracting solvent.
2. hydrophilic organic solvent: namely general said and the miscible organic solvent of water, as ethanol (claim again:Alcohol), methyl alcohol (claim again: another name for), acetone etc., the most frequently used with ethanol. The solubility property of ethanol is relatively good, to Chinese herbal medicine cellPenetration capacity is stronger. Outside hydrophilic composition isolating protein, mucilaginous substance, pectin, starch and part polysaccharide etc., large multipotency is at ethanolMiddle dissolving. Be insoluble in the lipophilic composition of water, the solubility in ethanol is also larger. Can also be according to the property that is extracted materialMatter, adopts the ethanol of variable concentrations to extract. More less than water consumption with alcohol extract, extraction time is short, dissolves water-solubleProperty impurity also few. Ethanol is organic solvent, though inflammable, toxicity is little, low price, and convenient sources, has a locking equipment to returnReceive Reusability, and the extract of ethanol is difficult for moldy metamorphism. Due to these reasons, with the method for alcohol extract be alwaysOne of the most frequently used method. The character of methyl alcohol is similar with ethanol, boiling point lower (64 DEG C), but toxic, when use, should note.
3. lipophilic organic solvent: namely general said and the not miscible organic solvent of water, as benzinum,Benzene, chloroform, ether, ethyl acetate, dichloroethanes etc. The selectivity of these solvents is strong, can not or be not easy to propose hydrophilyImpurity. But this kind solvent volatility is large, how inflammable (except chloroform), generally poisonous, price is more expensive, and equipment requirement is higher, and itPenetrate plant tissue ability a little less than, often need repeatedly to extract for a long time and could extract completely. If contained in medicinal materialMany moisture, is just difficult to leach its active ingredient with this kind solvent, therefore, while extracting herbal raw material in a large number, directly applies thisKind solvent has certain limitation.
(3) extracting method: use solvent extraction medicinal herb components, conventional infusion process, percolation, decocting method, reflux extractionAnd continuous circumfluence extraction method etc. Meanwhile, the factor such as the degree of grinding of raw material, extraction time, extraction temperature, appointed condition also can shadowRing extraction efficiency, must take in.
1. flood extraction method (being called for short: infusion process): the dipping genealogy of law packs herbal powder or fragment in suitable container into,Add suitable solvent (as ethanol, rare alcohol or water), dipping medicinal material is with the wherein method of composition of stripping. This law is fairly simple easilyOK, but leaching rate is poor, and as water be solvent, the easy moldy metamorphism of its extract, must note adding suitable anticorrisive agent.
2. permeating extraction (being called for short: percolation): percolation is that herbal powder is contained in percolator, constantly adds newSolvent, makes it penetrate medicinal material, flows out a kind of leaching method of leachate from top to bottom from percolator bottom. When solvent infilters medicinePowder, dissolved element proportion strengthen and while moving down, its position is just replaced in the solution on upper strata or rare immersion liquid, causes good concentrationPoor, diffusion energy is carried out preferably, therefore leaching effect is better than infusion process. But answer coutroi velocity, oozing in transient at any time from medicineOn face, supplement novel solvent, make in medicinal material till active ingredient fully leaches. Maybe ought ooze dropping liquid color extremely shallow or ooze the volume that gushes liquidWhile being equivalent to heavy 10 times of crude drug, just can thinking and substantially extract completely. Normal by rare leaching of collecting in a large amount of productionLiquid is as the use of the solvent of another batch of new raw material.
3. decoct extraction method (being called for short: decocting method): decocting method is traditional leaching method that China is used the earliest. Appearance usedDevice is generally pottery, sand tank or copper, enamel ware, should not use iron pan, in order to avoid liquid variable color. When straight fire heating, preferably often stirMix, in order to avoid that local medicinal material is heated is too high, be easily charred. Have the pharmaceutical factory of steam-heating apparatus, adopt more large reaction pot, large copper pot,Barrel, or pass into Steam Heating in the pond of cement block. Also several decocting devices can be connected to each other by pipeline, carry out continuouslyDecoct and soak.
4. heating and refluxing extraction method: the heating of application organic solvent is extracted, and needs to adopt reflux heating device, in order to avoid solvent evaporatesLoss. While operation in a small amount, can on round-bottomed flask, connect reflux condenser. The in-built medicinal material of bottle is about 20%~60% of capacity,Solvent soaked approximately 1~2cm of medicinal material surface. In water-bath, add hot reflux, general maintenance, seethes with excitement 3~6 hours, lets cool filtration, thenSolubilizer in the dregs of a decoction, does second and third time and adds hot reflux about half an hour respectively, or to till substantially putting forward most active ingredient. This method is carriedGet efficiency high compared with cold-maceration, the continuous extractions that adopt in a large amount of production more.
5. continuous circumfluence extraction method: application volatile organic solvent extract Chinese herbal medicine effective ingredients, no matter small test orLarge-scale production, all with continuous extraction for well, and need by quantity of solvent lessly, extract composition also more complete. Fat is commonly used in laboratoryFat extractor or title apparatus,Soxhlet's. Continuous extraction, generally needs a few hours could extract completely. Extract composition heated timeLong, the labile composition of case of thermal instability should not adopt this method.
2, Isolation and purification method
Extracts of Chinese herbal medicine or extract that said extracted method obtains remain mixture, need further remove impurity,Separate and refine.
(1) solvent segregation: be generally by above-mentioned total extract, select three, the solvent of four kind of opposed polarity, by low polarityExtract separation to high polarity substep. Aqueous extract or ethanol extract are often jelly, are difficult to be dispersed in low polar solventIn, therefore can not extract completely, can admix appropriate inert filler, as diatomite or fiber powder etc., then low temperature or natural drying,After pulverizing, then to select solvent to extract successively, make each constituent in total extract, according to its solubility in opposed polarity solventDifference and separated. Utilize Chemical Constituents of Chinese Traditional And Folk Medicine, the solubility in opposed polarity solvent is carried out separation and purification, isConventional method.
(2) solvent extraction:
1. extraction: solvent extraction extraction is called for short again extraction is to utilize in mixture each composition two kinds of phases not mutuallyThe difference of distribution coefficient in molten solvent and reach the method for separation. If each composition distribution coefficient in solvent differs when extractionLarger, separative efficiency is higher; If the active ingredient in aqueous extract is lipophilic material, general multiplex lipophilicity hasMachine solvent, as benzene, chloroform or ether extract, if active ingredient is to be partial to hydrophilic material, in lipophilic solventIndissoluble solution, just need to use weak lipophilic solvent, such as ethyl acetate, butanols etc. instead. Can also in chloroform, ether, add suitableAmount ethanol or methyl alcohol are to increase its hydrophily. While extracting flavones ingredient, multiplex ethyl acetate and water extraction. Extraction hydrophily is strongSaponin(e for multiselect n-butanol, isoamyl alcohol and water extract. But, common organic solvents hydrophily is larger, extracts with waterEffect just more bad because can make more hydrophilic impurities follow, on active ingredient, further refining impact is very large.
2. counter current continuous extraction method: be a kind of continuous solvent extraction. Its device can have one, several or moreExtracting tube. In pipe with little porcelain circle or the filling of little stainless steel wire ring, the contact-making surface when increasing solvent extraction. If a kind of medium-height grassThe infusion of medicine need to extract with benzene, the ethyl acetate etc. lighter than water, needs water extracting liquid to be contained in extracting tube, andBenzene, ethyl acetate are stored in high-level container. Extract whether complete, desirable for sample thin-layer chromatography, paper chromatography and chromogenic reaction orPrecipitation reaction checks.
3. counter-current distribution method: counter-current distribution method claims again CCD method, counter-current distribution or countercurrent distribution. Adverse current is distributedMethod is consistent with solvent counter-current extraction principle, but application of sample amount is certain, and continuous in the solvent of certain capacity, extracts through multi-shiftGet and distribute and reach the separation of mixture.
4. drop counter-current distribution method: drop counter-current distribution method claims again droplet countercurrent chromatography method. For distributing in adverse current in recent yearsImproved solvent extraction on method basis. To the substantially same counter-current distribution method of the selection of solvent system, but requirement can be at short noticeBe separated into, and can generate effective drop. Form mutually drop due to mobile, in thin distribution extracting tube with fix mutually effectiveGround contact, friction constantly form new surface, promote the distribution of solute in solvent, therefore its separating effect often distributes than adverse currentMethod is good.
(3) Flavonoids by Macroporous Adsorption Resin: macroporous absorbent resin is the class organic polymer growing up the sixties in 20th centuryAdsorbent, has good absorption property, be applied to gradually in the recent decade Chemical Constituents of Chinese Traditional And Folk Medicine extraction separate and inDeveloping of medicine new drug.
Macroporous absorbent resin is the parting material that absorption and screening principle combine. Its adsorptivity is because Van der Waals drawsThe result of power or generation hydrogen bond. Screening principle is because itself cellular structure determines. Due to absorption and screening principle, haveOrganic compounds, according to the size of the difference of absorption affinity and molecular weight, divides through certain solvent elution on macroporous absorbent resinOpen. This make organic compound especially the purification of water soluble compound greatly simplified. The skeleton of macroporous absorbent resin byStyrene and divinylbenzene polycondensation and generate, due to adding of modifier, the polarity of macroporous absorbent resin changes, according to treeThe surface nature of fat, that polymeric adsorbent is generally divided into is nonpolar, Semi-polarity and polarity three classes.
Nonpolar adsorption resin is not setting with the absorption of any function base of being made by the very little monomer-polymer of dipole momentFat. Typical example is the polymeric adsorbent of styrene-divinylbenzene system, as D101, XAD-1, DiaionHP-10 macroporous absorptionResin.
Semi-polarity polymeric adsorbent refers to the polymeric adsorbent containing ester group, as acrylate or methacrylate and two metering systemThe analog copolymer that acid esters etc. are crosslinked. It is on the basis of nonpolar macroporous adsorption resin, adds methyl acrylate or propyleneNitrile polycondensation forms, as the often AB-8 macroporous absorbent resin of use of China.
Polar Adsorbent Resin refers to that amide-containing, itrile group, phenolic hydroxyl group etc. are nitrogenous, the polymeric adsorbent of oxygen, sulphur polar functionalities base.In addition, sometimes the ion exchange resin of the ligand groups such as nitrogenous, oxygen, sulphur is called to strong Polar Adsorbent Resin, strong polarity absorption treeThe boundary of fat and ion exchange resin is difficult to difference. Polar macroporous adsorption resin can be by methyl methacrylate, acrylamideOr sulfoxide type polycondensation forms, as the XAD-10 of the DiaionHP2MG of Mitsubishi chemical industry, Rohm-hass company of the U.S., XAD-9 macroporous absorbent resins.
Compare with other adsorbent with active carbon, macroporous absorbent resin has advantages of a lot, as the suction to certain materialAttached selectively higher; Physical and chemical stability and mechanical strength are better; Description is more, can change as required resin physicsOr chemical constitution; Polymeric adsorbent is generally spherical particle, and fluid resistance is less etc. Thereby be widely used in chemical industry, medicineIn field, about macroporous absorbent resin, the report of the application study in natural product extraction separates is more and more in recent years. MacroporePolymeric adsorbent has certain to Chemical Constituents of Chinese Traditional And Folk Medicine as alkaloid, flavones, saponin(e, cumarin and some other methods of glycosidesSuction-operated. Very poor to sugared adsorption capacity, stronger to the adsorption capacity of pigment.
(4) precipitation method: be to add some reagent to make to produce precipitation in extracts of Chinese herbal medicine, to obtain active ingredient or to removeThe method of decontamination. As lead salt precipitation: lead salt precipitation is one of classical way separating some medicinal herb components. Due to vinegarLead plumbate and basic lead acetate, in water and alcoholic solution, can generate with multiple medicinal herb components lead salt or the complex salt precipitation of indissoluble, thereforeCan utilize this character that active ingredient is separated with impurity. Then lead salt precipitation is suspended in novel solvent, passes to stink dampBody, makes to decompose and to transfer insoluble sulfuration to plumbous and precipitate.
(5) salting out method: salting out method is in the water extraction liquid of Chinese herbal medicine, adds inorganic salts to finite concentration, or reaches capacityState, can make the solubility of some composition in water reduce Precipitation, and separate with water-soluble large impurity. Be commonly used for and saltoutInorganic salts have sodium chloride, sodium sulphate, magnesium sulfate, ammonium sulfate etc.
(6) dialysis: dialysis is to utilize small-molecule substance can pass through pellicle in solution, and macromolecular substances can notBy the character of pellicle, reach the method for separation. Otherwise also macromolecular impurity can be stayed in pellicle, and by little moleculeMaterial enter in the outer solution of film by pellicle, and separation and purification in addition.
(7) crystallization, recrystallization and Steppecd crystallization: qualification Chemical Constituents of Chinese Traditional And Folk Medicine, study its chemical constitution, first must beMedicinal herb components is prepared into monomer sterling. At normal temperatures, material nature is the compound of liquid, can use respectively fractionating processOr chromatography is carried out separation and purification. In general, Chemical Constituents of Chinese Traditional And Folk Medicine is the material of solid at normal temperatures mostly, all has knotThe general character of crystal, can reach according to the difference of solubility the object of separation and purification with crystallisation.
3, conventional drying method
(1) vacuum drying: be the general principle based on such: water saturation vapour pressure and temperature are closely related, in vacuumUnder state, the boiling point of water reduces, i.e. namely operation at low temperatures of operation under vacuum, can avoid at high temperature nutritional labeling asThe destruction of vitamin etc. has been improved rate of drying simultaneously. Vacuum drying is widely used in industries such as food, pharmacy, chemical industry,China also develops and has introduced various vacuum dryers, and its version is varied. Conventional form mainly contains box trueEmpty drier, double-cone type vacuum desiccator, belt vacuum desiccator etc. These traditional Minton dryers mainly adopt heatWind, the heating such as steam or electricity, utilize hot conduction, convection current or radiation theory heat to be passed to material inside from outside. Vacuum dryingHave baking temperature low, relatively hypoxia in hothouse, can avoid fat oxidation, and the series of advantages such as pigment brown stain, are suitable for heatSensitiveness food material dry, equipment cost, dry expense are also relatively low in addition.
(2) spraying is dry: be that fluidization technique is for a kind of dry method of liquid material. Because being wink-dry, suitable especiallyFor heat sensitive material, therefore products obtained therefrom quality is good, keep original color, smell and taste, and soluble. Utilize spraying to be dried to prepareThe research of micro-capsule is carried out, and it is that heart material is suspended in the solution of dress material, sprayed in thermal current through centrifugal atomizer,The product of gained is the micro-capsule that dress material bag heart material forms, and this micro-capsule powder can be used in direct tablet compressing, also can prepare capsule,Syrup or supensoid agent.
(3) freeze drying: be that dry liquid material is frozen into solid, utilize the sublimability of ice under low-temperature reduced-pressure conditionCan, low-temperature material is dewatered and reach a kind of dry method. Because material is dry under high vacuum and cryogenic conditions, therefore rightThe dry of some extremely thermo-labile article is well suited for. Wang great Lin has reported a kind of spraying ventilation freeze-drying new technology, is to utilize cold skyGas or nitrogen are as medium, and the scars of flowing through rapidly make water sublimate, and the product particulate that makes of spraying freeze-drying is little, fast drying, timeShort, even, good fluidity, and the good instant capacity of tool. In recent years, plaster material and the dry research of sticky material have been obtainedGreater advance, fluidization technology, spraying technique, inert carrier technology grow up on this Research foundation. RotationFlash dryer, thermojet pneumatic drier, inert carrier drying machine are all applicable to the dry of heat sensitive material and plaster material. ThisA little new achievements in research are produced for Chinese medicine preparation, by greatly improving the technical merit of Chinese medicine processing, enhance productivity.
(4) far infrared heating drying method: be a new dry technology, its drying principles is to change electric energy into far infraredRadiation, thus by the molecule absorption of medicinal material, produce resonance, cause vibration and the rotation of molecule and atom, cause object heating, warpCross thermal diffusion, evaporation and chemical change, finally reach dry object. Far-infrared ray drying can be saved electric energy 20%~50%, effectFruit better.
(5) micro-wave drying method: be the new technology developing rapidly a sixties in 20th century, microwave drying is actuallyBy eddy-current heating and dielectric heating, the moisture and the fat microwave energy absorbing to some extent that make to be dried in thing, and itThereby change heat into and reach dry object. Microwave drying can killing microorganisms and mould, and has disinfective action. At presentThe microwave heating installation that state produces has 915mhz and two frequencies of 2450mhz.
4, supercritical CO2Extracting process
(1) about the extracting method of animal and plant fatty oil component has: water-boiling method, hydrophily partition method, molecular clock and decompressionThat the way of distillation, metal add is legal, extractive crystallization process, point freezing milling process of dish and organic solvent method etc.
Adopt hot water bath method, because the heat time is long, temperature is high, easily make heat-labile volatile ingredient change,As the oxidation of some unrighted acids. Hydrophily partition method, the obvious advantage of this partition method is to have eliminated organic solvent method to causeHigh cost and public hazards, but the shortcoming of this technology is the saturated fatty acid that obtains and purity or the rank of unrighted acidBe not so good as Batteries by Organic Solvent Partition Process high. Molecular clock and distillation under vacuum, for reducing thermal denaturation, need come by methods such as urea adductsRemove most of saturated fatty acid, in the product obtaining, must be removed; Although can obtain purer aliphatic acid, need severalStep just can reach target, and more time-consuming, effort, has increased production cost. Metal adds the lower K cryogenic treatment of legal separation needs,After also to manage to remove metal ion, remove and not to the utmost also can cause metal ion pollution. Extractive crystallization process obtains aliphatic acid purityHigher, at lower temperature, carry out, can prevent the oxidation of aliphatic acid, but the time is longer, be not too applicable to large-scale industryChange and produce. Divide the freezing milling process shortcoming of dish to be, the refrigerating chamber of laying plate rail and hydraulic press needs area and the Pang of thousands of square metresLarge cooling system, large facility needs many people's operations, and labour intensity is high, and separating rate is slow, and efficiency is low, can not grasp continuouslyDo. Organic solvent method is to adopt benzinum or ether organic solvent under heating state, to carry out reflux cycle extraction in water-bath; ByIn adopted organic solvent as benzinum or ether etc. are a kind of low-boiling point material, inflammable and explosive, meanwhile, organic solventUse and pollute the environment on the one hand, organic solvent likely has residually in extract on the other hand, can affect extract doctorFurther application on medicine.
(2) about the supercritical CO of animal and plant fatty oil component2Extracting process: a kind of fluid is when being in its critical-temperatureDuring with pressure state, be called as supercritical fluid. Because the density of supercritical fluid is close to liquid, have and liquid flux phaseWhen extracting power. There is again the low viscosity suitable with gas, large 100 times than liquid of diffusivities, thereby have higherMass transfer performances. When adopting supercritical extract, utilize these character of supercritical fluid, make it to join with material to be separatedTouch and penetrate matrix, therefrom extract target substance. Then utilize the way of step-down and/or intensification to reduce its density, thereby reduceSolute solubility therein, makes extract and separated from solvent. Because different materials dissolves under identical extraction conditionsDegree is different, thereby likely by this species diversity, they is further separated. Supercritical fluid extraction is usually selected CO2DengLow and the chemically inert material of critical-temperature is extractant, and it is specially adapted to separating of heat-sensitive materials and readily oxidizable substance, because ofThis is highly suitable for separating for the extraction of animal fat. Therefore, the present invention takes the method, can prepare highly purified being carriedGet the fat oil of thing.
Supercritical CO2Extracting process is to extract like this: the meal of dry extract is placed on to supercritical extract and establishesIn standby, use CO2Extract, after decompression, obtain the fat oil of extract, under room temperature condition, be light yellow transparent oily; ExtractThe fat oil of extract in the purity of TFA more than 40, be better than other extracting methods; TFA generally comprisesOther components of oleic acid, linoleic acid, palmitic acid and surplus etc.
Supercritical CO2The method of the fat oil of extraction extract comprises the steps:
(1) dry extract is crushed to after 10~30 orders, is placed in supercritical extraction reactor, pass into continuously super facingCO under boundary's state2Extract, preferably condition generally: CO2Flow 10~55kg/hkg raw material, pressure 5~50Mpa,15~75 DEG C of temperature, time 0.5~6h; Further preferred condition generally: CO2Flow 45kg/hkg raw material, pressure35Mpa, temperature 50 C, time 1h;
(2) CO of fat oil of extract will have been extracted2Be decompressed to 1~12MPa, can obtain at ambient temperature byThe fat oil of extract, in the fat oil of extract the purity of TFA more than 40%, the physicochemical character of extract andAliphatic acid purity is all better than other extracting methods.
The selection of extraction conditions realizes by following way: first selected four factors, three levels, and according to orthogonal designMethod, by L9 (34) (orthogonal arrangement is with reference to Guo Zuchao chief editor " Medical Statistics ", people to hand over design table experiment arrangementPeople's militia cures publishing house, the first edition in 1999). From Orthogonal experiment results, analyze and be extracted process conditions.
To supercritical CO2The fat oil of the extract of extraction carries out, after methyl esterification of fatty acid, carrying out gas-chromatography~matterAnalysis of spectrum.
Supercritical CO2The preparation method of the fat oil of extraction extract does not with an organic solvent wait material, can not pollute, there is not the problems such as harmful dissolvent residual in environment yet, and easy and simple to handle, extraction time is short, product purity is high, the CO of use2Cheap and can repetitive cycling use, industrial production is with low cost.
(3) research overview of antineoplastic
Malignant tumour serious harm people's health, according to RST statistics, in the whole world 50 the more in hundred million populations every year on averageDie from malignant tumour person and reach 6,900,000 people, new cases are 8,700,000 examples, and numeral is also increasing year by year. Therefore, national governments, grindStudy carefully mechanism and drugmaker and tumor research and antineoplastic are paid much attention to for a long time always, at antineoplasticIn research, obtain at present major progress. The development of molecular weight tumor in recent years,, molecular pharmacology makes tumour essenceProgressively illustrate; The invention of the advanced technologies such as extensive rapid screening, combinatorial chemistry, genetic engineering and application acceleration medicine openThe process of sending out; The research and development of antineoplastic have entered brand-new epoch. Antineoplastic is just from traditional cell toxicantProperty medicine, to the new type antineoplastic medicine development of the too many levels effect for machine-processed.
Therefore, research and develop novel antineoplastic and become exigence. The large drug market table in the world seven in 2000Bright, the drug market of antineoplastic has increased nearly one times from more than 400,000,000 dollar of the mid-90 in 20th century, calendar year 2001 the whole worldNearly 1,200,000,000 dollars of market value; External analyst's prediction patient within Future Ten year will be increased to 20% left and right, medicine cityThe growth rate of field is by the rising having by a relatively large margin. Due to being on the increase of patient, the market sales revenue of medicine also alwaysIn steady-state growth. The nineties in 20th century, such medicine became situation of selling well medicine, nineteen ninety-five world's sales volume reached 5,000,000,000 dollars. 21Beginning of the century, the sales volume of such medicine has exceeded the treatment cardiovascular disease treating medicine, the treatment gastrointestinal disease medicine that are arranged in first threeWith the share in anti-infectives market, its growth momentum is good.
At present, such disease is more and more subject to China national and social great attention, and due to such disease classBe similar to the rich man's diseases such as diabetes, equally need long-term taking medicine, therefore its medication market along with aging population byFlaring is large, and market prospects are good. Based on this, for understanding in time the market situation of Chinese medicine, China national food and medicineSurveillance Authority south information centre of medication economics research institute choose six main medication cities of China (Beijing, Shanghai, Guangzhou,Nanjing, Hangzhou, Chengdu) various schools of thinkers sampling hospital, 60 doctor experts and 120 consumers, to China medication market(1999 and 2000) and mainly compete kind and carried out comprehensive market survey activity.
Medicine sell data show, global pharmacy corporation the last 50 is 2.8% at the prescription medicine sale growth of 2007,And wherein antitumor class medicine growth is the fastest, reach 14%. 2006 annual datas show equally, the pin of antineoplastic in 10 class medicinesSell growth and rank first, reach 20.5%. This has reflected the continuing of antineoplastic, the market demand of rapid growth. China is in systemOn the basis of fixed medium-term and long-term scientific development planning, propose to set up a collection of great special project. " great new drug initiative " is from Eleventh Five-Year PlanTo one of national major project of supporting between the year two thousand twenty. This project will be for the multiple serious harm people such as tumour, cardiovascular diseaseMajor disease, development original new drug. Clearly, the research and development of anti-cancer agent, are control serious harm people diseasesSick needs are also the vital tasks of Chinese sustainable development and construction innovation-oriented country. What " great new drug initiative " was special sets up,To the process of Chinese anti-cancer agent research and development be produced to active influence.
Treatment of cancer is the great difficult problem of Med Biol. Development can be effected a radical cure the medicine of tumour, still " shoulders heavy responsibilities ".Compared with advanced international standard, China is still having big gap aspect anti-cancer agent research. The research of anti-cancer agent with openSending out is a difficult task, is long-term, a complicated process, needs scientific and technical personnel to work without single devotion for a long time with long-pendingTired. Therefore, need to provide stable working environment and condition for researcher; Need each side professional and associated mechanisms concerted effortCooperation; Need to be conducive to promote Guaranteeing measures of policy and the organizational coordination mechanism of cooperation; Need to have larger amt funds to comprise facesThe support energetically of the funds of research and clinical research before bed.
Current, anti-cancer agent research and development are faced with good opportunity. Chinese Medicine the reach of science, various novel for developingAntineoplastic provides important theoretical foundation and new technical support. The development of Health Care in China cause, to comprising cancerDisease is had higher requirement at interior therapy of serious disease medicine, and the great demand of Chinese market and world market can be given research and developmentUnit brings considerable economic benefit. China sets up " great new drug initiative " great special project, will greatly promote that Chinese new drug comprisesThe research and development of anti-cancer agent.
Treatment of cancer medicine accounts for the 7th of world's drug market, is worth 6,100,000,000 dollars to the end of the year 2005. And it is anticancer at presentDisease drug is mainly relief of symptoms, does not contain the development of the state of an illness. Therefore,, in conjunction with Chinese Chinese traditional herbs, therefrom excavate and haveThe medicine of effect, low toxicity, inexpensive treatment cancer, seeking a kind of effective methods for the treatment of, to stop potential pathogenic process be very mustWant, so it is considered herein that development is for preventing, diagnose, detect, protect and the particularly medicine tool of product of the aspect such as treatmentThere is very important meaning, also can produce significant Social benefit and economic benefit.
The cancer research of several important kind that just wherein the present invention pays close attention to is below summarized.
(4) progress of lung cancer
1, general introduction
Primary bronchogenic carcinoma of lung (abbreviation lung cancer), is modal malignant tumour in the world at present, has every year 102100000 newly-increased cases, wherein non-small cell lung cancer accounts for 80%. Lung cancer is China's the first lethal cancer especially, has every year 600000 patientsDie from lung cancer.
The incidence of disease and the fatal rate of lung cancer rank first, account for 16% of whole malignant tumours, all cancer mortality number28%, the serious harm mankind's health. Although operation, radiotherapy, chemotherapy become three large sharp weapons for the treatment of lung cancer, ChineseThe incidence of disease of lung cancer is always in rising trend, increases progressively every year on average 11.9%, expects 2025, the annual new pulmonary carcinosis of ChinaNumber can reach 1,000,000 people, becomes first lung cancer big country. Chinese Medicine is also being brought into play in the lung cancer control of countries in the world can notAlternative effect, has obtained the achievement attracting people's attention, and has been subject to paying close attention to widely.
2, pulmonary carcinosis because of research
Pulmonary carcinosis is because of 1. smoking; 2. physical chemistry carcinogen; 3. atmosphere pollution; 4. chronic Pulmonary Diseases and body are exempted fromEpidemic disease hypofunction; 5. endocrinopathy and 6. Family genetic factors etc.
American scholar Minna in 1998 by perspective to lung cancer occur, molecular pathology research in evolution, carryGo out the genetic mutation pattern of lung carcinoma cell: 3P gene loss → 9P gene loss and ras gene mutation → carcinoma in situ (p53,17p13.3 gene mutation) → invasion of lung cancer or transfer (p15, p16, C-myc, c-erB2, EGFR gene mutation). No. 10 dyeingThe phosphatase that body is lost and tensin homologue (be called for short: PTEN) gene is a tumor suppressor gene with phosphatase activity,PTEN positive expression is starkly lower than normal lung tissue in cancerous lung tissue, and it may participate in development and the infiltration of lung cancer and turnMove.
In lung cancer all there is the abnormal of 26S Proteasome Structure and Function in p16 gene, proved the generation phase of p16 gene inactivation with lung cancerClose. P15 gene is newfound CDKN2, and its product p15 albumen cell growth plays down regulation, vascular endothelial growthThe factor (is called for short: VEGF) be one of angiogenic factors, tumour cell produces VEGF, has important in tumor vessel generatesMeaning. P15 gene is by regulating VEGF to control the generation of blood vessel, and this contributes to find the development mechanism of tumour.Survivin is that a kind of human body cell IAP of recent findings (is called for short: hIAP), be minimum hIAP albumen.Survivin gene may be by suppressing Increase Apoptosis of Lung Cancer Cells, and generation, development to lung cancer play an important role.
3, lung cancer parting and epidemiology survey
(1) lung cancer somatotype substantially
1. position somatotype
Centre type: the bronchus that the tumour section of occurring in is above;
Peripheral: the bronchus that the tumour section of occurring in is following;
Diffuse type: at bronchiole or alveolar, fill the air and be distributed in two lungs.
2. Type of injury
Intracanalicular type, tube wall infiltrative type, nodular type, block type, Differentiation of Diffuse Invasive.
(2) the clinical common histological classification of lung cancer
Lung cancer from can be divided into substantially ED-SCLC (be called for short: SCLC) and non-small cell lung cancer (abbreviation: NSCLC). ItsMiddle major part is non-small cell lung cancer, accounts for 80%, and ED-SCLC accounts for 20%. Approximately 65%~70% non-small cell lung cancerWhen medical just in late period.
1. non-small cell lung cancer
Phosphorus cancer: tend to, to bronchial wall growth, also send out to central authorities, form central authorities' property downright bad and empty. And easily blockTube chamber causes obstructive pneumonia. And easily invade blood vessel lymphatic vessel and backward DISTANT METASTASES IN.
Gland cancer: mostly be peripheral pulmonary parenchyma lump. Can invade in early days blood vessel, lymphatic vessel, the primary tumor of being everlasting causes symptomBefore shift.
Maxicell lung cancer: this class tumor growth is rapid, often invades lymph node, blood vessel and distant place organ.
2. ED-SCLC: often occur in large bronchus, how to have transferred to hilus pulumonis and mediastinal lymph nodes in early days, owing to easily invadingViolate blood vessel, in the time of diagnosis, the existing lung of great majority shifts outward.
Lung cancer metastasis and recurrence: lung carcinoma cell often follows lymphatic dissemination to hilus pulumonis, mediastinum, clavicle and axillary lymph knotDeng, it can directly invade blood vessel, and cancer embolus occurs, and causes DISTANT METASTASES IN. Liver, brain, adrenal gland, bone, hypodermis etc. are the most commonMetastasis site, lung cancer likely forms extensive lymphatic channel and Blood route metastasis in early days.
Lymph Node Metastasis: head is shown in bronchopulmonary lymph nodes, paratracheal lymph nodes, lymphonodi cervicales, hilar lymph node, mediastinal lymphKnot.
Hematogenous metastasis: be common in brain, adrenal gland and kidney.
Causes of recurrence: postoperative not complex treatment, uncertain its check.
The incidence of disease of lung cancer present with the industrial area in city taper off to surrounding rural area distribute trend. The morbidity of lung cancerRate increases with age growth, within 40 years old, rises rapidly later, within 50~60 years old, rises remarkable especially, within 70 years old, slightly decline later, and manProperty is higher than women, and men and women's ratio is 3~7.1: 1.
4, the progress of pulmonary cancer diagnosis
The early diagnosis of lung cancer is the effective way that improves result for the treatment of, is also the key factor that determines patient's prognosis, butLack at present effective early diagnosis means. Molecular biology research result contributes to the early diagnosis of lung cancer, iconography and phlegmThe progress of liquid exfoliative cytology is also for the early diagnosis of lung cancer provides advantage.
(1) lung cancer clinical manifestation
Lung cancer symptom is divided lung cancer early symptom and advanced lung cancer symptom, in early days how not obvious, middle and advanced stage expectoration, hemoptysis, pressureCompel symptom typical case. Obviously whether the symptom of lung cancer, is the signal of interest of the diagnosis early stage of lung cancer, and advanced lung cancer easily occurs to shift as brainTransfer, Lymph Node Metastasis, bone shift, hepatic metastases.
1. lung cancer early symptom: the most common cough, spitting of blood, pectoralgia and heating.
Lung cancer early symptom: excitant dry cough, white mucus spume sample phlegm, blood-stained sputum silk or hemoptysis, or pectoralgia, chestDiscomfort, expiratory dyspnea and fever etc.
2. lung cancer middle and advanced stage symptom:
Bronchial obstruction: make gas be difficult for discharging, form obstructive emphysema. When lump is grown up, even atelectasis.
Infect: occur obstructive pneumonia, when serious, can form pulmonary abscess.
Compressing and metastasis symptom: compressing brachial plexus nerve causes brachialgia, paralysis, amyotrophia, sensorimotor function obstacle etc.; FoodRoad is invaded or can be produced to swallow when pressurized to be blocked; Nervus phrenicus is invaded generation phrenoparalysis; Recurrent nerve is invaded, trachyphonia; Compressing is invadedThe vena cave of going against one's superiors, causes superior vena cava syndrome, has giddy, dim eyesight, Head And Face and upper limbs swelling, front venous engorgement; InvadeWhen pleura, there is hydrothorax, when pericardium is invaded, can occur hydropericardium.
Other symptoms: the joint symmetry enlargement pain of long bone, acropachia (toe) etc., the skins such as itch all over and nettle rashSymptom.
(2) lung cancer sign
Localized wheezing sound, hoarseness, superior vena cava syndrome, shoulder arm pain, diaphragmatic paralysis, dysphagia, the heartBag is invaded, pleura shifts, lung shifts outward.
(3) pulmonary cancer diagnosis main points
1. x-ray rabat is found Solitary pulmonary nodule or lump, or has bronchial obstruction sign through CT examination, should doubt as lungCancer.
2. the long-term smoking male sex is more than 40 years old, and irritable cough, accompanies spitting of blood on a small quantity, and rabat is found limitation focus, anti-inflammatoryTreating tuberculosis (2~4 weeks) is invalid or focus counter become increase.
3. obviously out of breath, cough, x-ray rabat both sides are millet appearance or dispersivity focus, should get rid of miliarytuberculosis, lung turnsMove the pathology person such as cancer, pneumomycosis.
4. find in the heart lung's piece shape, with hilus pulumonis or (with) mediastinal lymph node enlargement, and occur superior vena cava block, larynxThe neural blood vessel pressure symptoms such as nervus recurrens paralysis, or with distant place lymphatic metastasis person.
5. cytolgical examination or the biopsy person of clarifying a diagnosis.
(4) other auxiliary diagnosises
(be called for short: TTF-1) be a new tumor markers of recent findings, main and first shape the Thyroid metastasis factor-1Adenoncus knurl is relevant with lung neoplasm. Detect the diagnosis that TTF-1 can effectively improve lung cancer. The sun of TTF-1 in ED-SCLCProperty rate is 81%~100%. 1996, Byrd-Gloster differentiated adenocarcinoma of lung and the outer gland cancer of lung with TTF-1, in result adenocarcinoma of lungTTF-1 positive rate is 76%, and the outer gland cancer positive rate of lung is 0, shows that TTF-1 is for differentiating that the outer gland cancer of adenocarcinoma of lung and lung has importantMeaning.
Specific neuronal anti Hu antibody is to come across paraneoplastic neurologic syndromes (to be called for short: one spy PNSNS)The opposite sex, sensitiveness antibody, PNSNS is mainly seen in ED-SCLC, and anti-Hu antibody is 20% left and right at the positive rate of SCLC, and thisTime tumour in the early stage radical cure stage, therefore, significant to early diagnosis ED-SCLC.
Telomerase is the tumor markers of generally acknowledging at present known wide spectrum the most. The hand of Kumaki to 115 routine patients with lung cancerArt sample detects, and positive rate of telomerase is 93%. Wherein the telomerase activation of ED-SCLC is significantly than other typeCancer telomerase activation is high. Telomerase activation detect conjunctive tissue and cytolgical examination can improve pulmonary cancer diagnosis rate be 90% withOn.
Iconography is irreplaceable in the effect of diagnosing. The disease of 2~3mm can be accurately found in spiral CT inspection at presentKitchen range. And positive electron fluorescent scanning (is called for short: PET) can be used for discriminating good before performing the operation, malignant tumour. In conjunction with fine needle aspiration biopsy orThoracoscope biopsy can draw reliable diagnosis. In recent years Imaging Technology is constantly progressive, and new technology is examined as Virtual bronchoscopeLook into, low-dose spiral CT inspection hinders diagnostic method in conjunction with Wicresoft, can obviously improve the early diagnosis of lung cancer.
The fluorescence bronchoscope developed the nineties in 20th century (be called for short: LIFE), its operation principle be with wavelength be 400The blue light illumination bronchial tree of~440nm, bronchoscope connects high-resolution camera, and the image of look-out station is passed through to dataConverter input computer, is finally reflected into the image of look-out station on fluorescent screen. Normal structure is sent green glow, and precancerosisChange, carcinoma in situ and early invasive carcinoma are sent different ruddiness, LIFE to the diagnosis of precancerous lesion and carcinoma in situ than common Bronchofiberscope1.5~6.3 times are improved. Also high than the common Bronchofiberscope degree of accuracy to infiltrating carcinoma. Another kind of fluorescence Bronchofiberscope is Storz bronchusMirror, it only with white light by blue filter as exciting light, and without laser and high-resolution camera, patient need first take 5-Aminolaevalinicacid (is called for short: ALA), to strengthen the autofluorescence intensity of pathological tissues, can make like this precancerous lesion portionStronger ruddiness is sent in position, strengthens the colour contrast of diseased region and normal structure, is conducive to find precancerous lesion, improves early stageDiagnosis. But fluorescence Bronchofiberscope is mainly used in central type carcinoma of lung, and specificity is lower, approximately 33%.
Mediastinoscopy and thoracoscopy can be understood accurately to thoracic cavity endolymph knot transfer case, are convenient to accuratelyLung cancer is carried out by stages, the prognosis of lung cancer is judged. Its degree of accuracy reaches 93%~100%, and effect is as open chest surgery.
Clinically by the pathological examination of imaging examination and operation find no shift be diagnosed as early stage non-little, also may there is invisible transfer in the patient of cell lung cancer, be called micrometastasis (Micromestasis). How to find micrometastasisIt is the hot issue of studying at present. Current research mainly concentrates on lymph node, marrow and peripheral blood aspect. Molecular biologyLearning a skill with molecular immune is the Main Means that detects micrometastasis.
5, the progress of lung cancer therapy
The treatment of lung cancer is taking multidisciplinary synthesis treatment as principle, as operation, radiotherapy, chemotherapy, physical treatment, immunization therapy,Biological therapy, targeted therapy, traditional Chinese medical herbal treatment. The Chinese medicine two of the main point lung cancer Western medicine of lung-cancer medicament classification and treatment lung cancer is largeClass, although treatment lung cancer does not have specific drug, along with lung cancer therapy progress, anti-lung cancer medication is imitated significant medicine as easily auspiciousSand, Erlotinib, chloroxoquinoline, clearing lung-heat Sanjie Pill, Jin Fukang, the evergreen capsule of compound, cantharides capsule, purple Long Jin etc., through facingBed checking is evident in efficacy and be widely used in the treatment of lung cancer.
(1) therapeutic purposes
Suppress to greatest extent or tumors destroyed. Whole body therapeutic and topical therapeutic; There is operation idicatio person, first-selected operation.Intra-operative or (with) operation after, no matter whether chemoradiotherapy all should coordinate traditional Chinese medicine, for complex treatment, (targeted therapy, biology are controlledTreatment, PCI, etc.) create conditions, reduce tumour diffusion transfer, improve symptom, extend life cycle, improve life quality.
(2) lung cancer therapy principle
1. therapy for small cell lung cancer principle: general not first-selected operative treatment in principle, taking chemotherapy and radiation as main, in cooperationDoctor's Chinese medicine.
2. Treatment for Non-small Cell Lung principle: Lymph Node Metastasis is remarkable, in preoperative auxiliary taking operation as main to I, II, IIIA phaseWith chemoradiotherapy. The IV phase, (having transfer far away) person cannot perform the operation, and can consider to accept chemoradiotherapy, extended life cycle, improved life quality, to the greatest extentAmount strives for being with knurl long term survival.
Anti-non-small cell lung cancer new approaches: " recognizing " accurate cell is treated again
Under normal circumstances, accepting after the treatment of various chemotherapy regimens, the gross tumor volume of Patients with Non-small-cell Lung can be byStep is dwindled, but still has part cancer cell " to flee from " drug effect, occurs diffusion, and continued growth. A few days ago, U.S. Dana-Farber ICR and Massachusetts Quan Ke hospital (are called for short: MGH) researcher of Cancer center delivers on " cancer cell " magazineArticle, thinks if can confirm the patient that this part occurs cancer cell diffusion, and with the pharmaceutical admixtures that initial stage is used combine intoRow treatment, can make patient's the state of an illness paracmasis continue the longer time.
Research has been chosen Patients with Non-small-cell Lung with EGFR gene mutation (with the patient of EGFR gene mutation approximatelyAccount for U.S.'s Patients with Non-small-cell Lung 12%), conventionally, this part patient is at the protein-tyrosine of accepting taking EGFR as target cellInhibitors of kinases class medicine, after the treatment of Erlotinib (Tarceva) or Iressa (Gefitinib), tumour there will be volumeThe reaction such as obviously dwindle.
Research group has found a kind of phenomenon several years ago, originally at Erlotinib (Tarceva) or Iressa (Ji FeiFor Buddhist nun) Chemotherapy under dormant non-small cell lung cancer cell, can reenter another one growth cycle, for this reason,Researcher thinks that these cells have produced drug resistance to medicine. And these cells all contain a large amount of MET gene magnification conventionallyThing. In this research, researcher has found again a kind of new phenomenon: even press down not yet starting to accept protein tyrosine kinaseBefore preparation for treating, in the Patients with Non-small-cell Lung body of part with EGFR gene mutation, just occur what fraction increasedMET cell. Researcher also finds, this sub-fraction cell can be (to be called for short: HGF) excite tumour by HGFCell produces drug resistance.
Researcher represents, HGF plays a role by diverse two approach, and produces drug resistance. First, it canProduce Growth of Cells signal by GAB1 albumen. Secondly, it is by promoting the generation of MET propagation cancer cell, to guarantee that they becomeTopmost cell type in tumour cell. Research shows, although non-small cell lung cancer tumour cell contains few before treatmentThe MET proliferative cell of amount, if but by special medicine and tyrosine kinase inhibitor use in conjunction for this class cell, curative effectCan be more remarkable.
Researcher sums up and thinks: " our research provides a kind of brand-new thinking, at the treatment initial stage, part is suffered fromPerson carries out the therapeutic scheme of Drug combination, is especially proved to be at the very start and in body, exists MET amplified matter for thosePatient, more should be like this. Before treatment, patient's tumor cell type is carried out to a multianalysis, will contribute to determineThe response situation of patient's later stage to therapeutic scheme, thus make clinician can more accurately formulate therapeutic scheme, withAvoid to large degree the generation of drug resistance. "
(3) methods for the treatment of
1. operative treatment: operation excision is the most effective means for the treatment of at present lung cancer, as much as possible removal of lesions was andThe lymph node shifting is the precondition that improves patients with lung cancer survival rate. Minimally invasive surgery is the new technology of in recent years carrying out, as chestEndoscope-assistant surgery, little to patient trauma, but can not pursue Wicresoft wound and abandon Operative Range. The standard procedures mode of lung cancerFor lobectomy of lungs.
2. chemotherapy: chemotherapy brings up to current approximately 70 to the remission rate of ED-SCLC from 40% of early 1980s~80%, and the remission rate of non-small cell lung cancer brings up to 35~45% from 15%, due to the research and development of medicine, has alleviated malicious secondary workWith, increase curative effect.
Current lung cancer chemotherapy scheme is mainly platinum containing regimens, NACT and full dose band knurl chemotherapy after can performing an operation. 20Having 70~eighties of century scholar to think can, by chemotherapy by the reduction by stages of lung cancer, improve Resection Rate, but disputeLarger. Because ED-SCLC is comparatively responsive to chemotherapy, curative effect is better, no matter local lesion is dwindled or to control micrometastasis kitchen range equalBeneficial, thought in the past that ED-SCLC was not suitable for operation, the excision of can performing the operation again after chemotherapy, is therefore again preoperative auxiliaryizationTreat, on therapy for small cell lung cancer, have certain status, simultaneously also for the development of non-small cell lung cancer induction chemotherapy has established oneFixed basis. Preoperative chemotherapy cycles number is generally advisable with 2~3 cycles, exceedes for 3 cycles above can cause pleaural adhesion, fiberChange and cause operating difficulty increase, increase complication. Be reported in one group of 484 routine statistics, think induction chemotherapy after remission rateReach 65%, the mean treatment death rate is 7%, and survival rate is longer, has statistical significance. The effect of preoperative new adjuvant chemotherapy in recent yearsBe under suspicion, no matter think from Resection Rate, median survival interval, 5 years survival rates, whether do Neoadjuvant chemotherapy withoutNotable difference.
Also there is dispute in postoperative chemotherapy, whether postoperative chemotherapy useful arguement always, until 2003 at U.S. ASCO(Americansocietyofclinicaloncology), in meeting, LeChevalier etc. have reported that 1867 examples are postoperative3~4 cycle random research of chemotherapy two generations platinum containing regimens, chemotherapy group is compared 5 years survival rates with chemotherapy group not and is respectively 44.5%Be respectively 39.4% and 34.3% with 40.5%, 5 year Progression free survival rate, median survival interval is respectively 50.8 months and 44.4Month, be better than not chemotherapy group, there is statistical significance. And chemotherapy group 23% (neutrophil leucocyte toxicity) has >=the IV level toxicity of 1,Die from chemotherapy person and account for 0.8%, scholars think that above-mentioned study on large sample can illustrate the effect of postoperative chemotherapy at non-small cell lung cancer,But to the effect of asynchronous non-small cell lung cancer, if first phase non-small cell lung cancer is because pathology is limited to, whether NACT to be,Need further to be studied.
The method of administration of chemotherapy also has multiple, except conventional systemic vein administration, also has Catheterization of Bronchial Artery perfusionChemotherapeutics, Bronchial Arterial Chemotherapy drug infusion add the method such as arterial embolism, tumor by local puncture administration.
The medicament selection of chemotherapy: through a large amount of clinical analysis, tumour association of the U.S. (is called for short: ASCO) think and select at presentBest as basic combined treatment curative effect taking platinum class, First-line chemotherapy medicine is recommended two regimens, to not using platinum class medicineThe patient of thing, the non-platinum class scheme for combining of two new drugs of recommendation. The chemotherapy new drug for the treatment of lung cancer mainly contains taxol (Thailand at presentElement), gemcitabine (gemzar), vinorelbine (NVB). And the up-to-date medicine using in China is Alimta.
Does is best chemotherapy cycles how many for suitable? thought in the past, chemotherapy should be with 2~8 cycles for well, recently BritainA result of study demonstration, continuously uninterrupted chemotherapy is not tolerant to most patients, and only can increase toxic action, alsoDo not have evidence prompting to increase result for the treatment of, show, after 3~4 cycle chemotherapy, the remission rate of most patients no longer improves,Extend chemotherapy cycles and only can increase toxicity, therefore, the optimal period of chemotherapy is to be suitable in 3~4 cycles.
3. radiotherapy: radiotherapy is one of primary treatment means for the treatment of lung cancer, but little alone radiotherapy is as unique treatmentMeans. There are chemotherapy and companion's row Radiotherapy chemotherapy after chemotherapy before preoperation radiotherapy, postoperation radiotherapy, radiotherapy, radiotherapy the opportunity of radiotherapy. RadiotherapyDosage has half amount radiotherapy and curative radiotherapy. Various radiotherapy patterns all have relevant bibliographical information above, generally speaking, and preoperation radiotherapyCan only reduce local relapse, without benefit, can only increase operating difficulty to lymphatic metastasis and DISTANT METASTASES IN, can not extend existenceTime. And the prolongation in various degree of other radiotherapy pattern patient's life span. Companion's row Radiotherapy chemotherapy increase cytotoxicity andDigestive tract reaction, increases complication rate, and therefore application is restricted.
4. immunization therapy: patients with lung cancer often presents immunologic function and suppresses, and immunologic function is lower, and prognosis is poorer. At presentImmunization therapy is mainly divided into active immunotherapy, passive immunization therapy and gene therapy. Active immunotherapy is divided into again non-specificProperty active immunotherapy and specificity active immunotherapy. Non-specific active immunotherapy application has immunoregulation effectStimulating factor, by the immune system of nonspecific effect excitating organism, strengthens anti-tumor immune response, as BCG vaccine, short and smallCorynebacteria etc., but its poor specificity, DeGrain. The difficult point of specificity active immunotherapy is escaping of tumour antigenEase, some common tumour antigens are used for making anti-tumor vaccine as CEA, MUC1, GD2, HuD etc. And dendritic cells (letterClaim: DC) cell vaccine is current focus. Experiment shows, the dendritic cells of derived from peripheral blood, when itself and the gland cancer of processingThe non-small cell lung cancer cell co-incubation that clone or operation are taken out, can be clear and definite under Electronic Speculum or flow cytometerLower discovery dendritic cells picked-up tumour cell, the more important thing is, the gland cell system of dendritic cells delivery can be effectively byTumour antigen absorbs and is passs T cell, thereby excites corresponding immune response. There is at present multinomial lung cancer associated antigen researchUnderway, some has entered the III phase clinical trial stage, and the progress of lung cancer vaccine is fast, desirable. PassiveImmunity is divided into again adoptive immunotherapy and antibody therapy, and adoptive immunotherapy is the antitumor activity that has self or allosomeImmune serum or immunocyte input patient body in, reach antineoplastic object, but result of use is not good separately. Antibody therapyJust becoming another study hotspot of lung cancer, the acceptor of growth factor, cell factor, protease C, cyclooxygenase 2 is that lung cancer is controlledThe targeting site for the treatment of, uses corresponding monoclonal antibody to be combined with the oncogene of unconventionality expression and can block the abnormal of cancer cellSignal transduction pathway, thereby the development of prevention cancer. Gene therapy is inseparable with immunization therapy, intersects each other, divides in recent yearsSub-biology techniques and recombinant DNA technology fast development, for the monoclonal antibody of oncogene as HER-2 monoclonal antibody,For complementary lung cancer therapy. Gene therapy key is Gene transfer techniques, and current most of carrier is virus. Controlling of geneTreating strategy is (to be called for short: TAAs) in the gene of coded sequence importing human body, excite corresponding anti-containing specific tumour necrosis factorFormer passing held cell and passed and hold to T cell (being mainly tumor-specific cytotoxicity T lymphocyte CTL cell), thereby producesImmune response killing tumor cell.
The lung cancer secret of falling ill has in early days been local late period when most of non-small cell Finding case disease or shift,Miss surgical engine meeting. The appearance of targeted drug, brings the hope of existence to the patient of chemotherapy failure.
5. physical treatment: utilize heat, cold physical means to treat tumour, thermotherapy aspect, adopts ultrasonic wave to tumour office morePortion is heated to 40~45 DEG C, continues 30~40 minutes, reaches the object of killing off tumor cells, and cold therapy is also basic identical, profitTo-180 DEG C~-190 DEG C, continue 10~30 minutes by cooled with liquid nitrogen tumour, make tumour cell intercrystalline, break, kill tumourCell. Physical treatment is used when patient is without too many treatment means late, and its effect is also limited, only have dwindle swollenThe effect of knurl focus.
6. traditional Chinese medical herbal treatment: traditional Chinese medicine is mainly to treat the lung of late period without special treatment in the application for the treatment of lung cancerCancer patient, improves symptom with Chinese medicine, improves the quality of living, and extends life span; Reduce the toxic and side effect of chemotherapy radiotherapy, improve and treatEffect. Strengthening vital QI to eliminate pathogenic factors, to treat both principal and secondary aspect of disease be the basic principle of Chinese traditional treatment lung cancer. Lung cancer is divided into four types by the traditional Chinese medical science: qi-deficiency type, the deficiency of YinType, type of deficiency of both QI and YIN, the malicious type of phlegm heat silt. According to diagnosis and treatment based on an overall analysis of the illness and the patient's condition, therapy of combing traditional Chinese and Western medicine, has obtained certain curative effect, but always reportsRoad number of cases is few, and repeatability is not strong. In addition, the traditional Chinese medical science is emphasized dietetic treatment, thinks the anti-lung cancer soup of yellow croaker (root of large-flowered skullcap, sealwort, fish raw meatGrass, PERICARPIUM TRICHOSANTHIS, fritillaria thunbergii etc.), david lily pig lung decoction, fig cordate houttuynia soup etc. have certain help to patients with lung cancer.
(5) progress of cervical carcinoma
1, general introduction
Cervical carcinoma (cervicalcancer, be called for short: CC) be one of modal malignant tumour in global women, only inferiorOccupy second in breast cancer, particularly common in developing country, be one of gynaecology's three large malignant tumours. According to uniting in world wideMeter, the annual cervical carcinoma new cases that approximately have 500,000 left and right, account for 5% of all cancer new cases; The World Health Organization points out,New cases 90% are from developing country, just have a women to lose because of cervix cancer every two minutes.
2, the cause of disease
Cervical carcinoma is to cause the principal element of global women because of cancer mortality. Along with going deep into of medical research, find a lotHazards are all closely related with the generation of cervical carcinoma, and it is summarised as to virulence factor, host, ring by epidemilogic triangle patternThree, border key element. HPV virus (people's papilloma sample virus, English in more than 90% Cervix Squamous Cell cancerous tissue, are detectedLiterary composition: existence humanpapillomaviru); 40 years old following adenocarcinoma of the uterine cervix women, 89% infects HPV virus, and more than 60 years oldIn female population, its infection rate is only 40%.
HPV virus infections is the major reason of cervical carcinoma, but is not unique factor. No matter smoking is active or quiltMoving smoking can cause cervical carcinoma. Oral contraceptive is also one of key factor, and the more than 5 years women's illness rate of taking medicine increases by fourDoubly. The factors such as other morning and evenings that start as socioeconomic status, schooling, marriage or sexual behaviour, fecund, nutrition have necessarilyEffect. In the situation of HPV virus sustainable existence, many factors acting in conjunction has damaged the immunologic mechanism of cervical epithelial cells.The generation of cervical carcinoma and sexual's number and the age of sexual behaviour are for the first time in close relations. Cervix Squamous Cell cancer and fecundClose relation, the childbearing age is early all close with SCC, gland cancer relation.
HPV virus 16 types and 18 types in cervical cancer tissues, detected from application nucleic acid hybridization techniques such as Durst in 1999Since DNA, Zhang etc. (2002) carry out the correlation of HPV and cervical carcinoma to different aspects such as molecular biology from clinicalLarge quantity research, thinking that the morbidity of cervical carcinoma is main infects and causes that body endogenous factor exerts an influence with HPV, as the cancer base of being correlated withBecause of activation, tumor suppressor gene inactivation, telomerase activation high expressed and a series of pathological changes such as Organism immunoregulation mechanism is unbalance, drawPlay Cell apoptosis and proliferation dysregulation, cause tissue canceration.
Prevent early screening and effectively control for these hazards, for reversing precancerous lesions of uterine cervix, blocking-upThe development of its pernicious behavior has great significance.
3, symptom
Colporrhagia: young patient often shows as contact bleeding, occurs in sexual life, gynecologial examination and hemorrhage after an action of the bowels.Amount of bleeding is the amount doesn't matter, generally according to size of tumor, invade and interstitial in the situation of blood vessel determine. Early stage amount of bleeding is few, late period diseaseKitchen range shows as and bleeds profusely more greatly, may cause mortality massive haemorrhage once corrode compared with trunk. Young patient also can show asMenostaxis, cycle shortening, menorrhagia etc. Irregular colporrhagia after the normal main suit of gerontal patient menopause.
Neoplasm: patient often tells neoplasm and increases, white or courageous and upright, thin in water sample or thin rice gruel sample, there is stench taste.Because of cancerous tissue ulceration, necrosis, scabies secondary infection etc., have a large amount of purulences or thin rice gruel sample fetor ex vagina to discharge late period.
The symptom of late cancer: occur Secondary Symptom according to focus infringement scope. Focus involves pelvic cavity connective tissue, pelvisWhen wall, compressing ureter or rectum, sciatic nerve, often tell frequent micturition, urgent urination, rectal tenesmus, constipation, tenesmus, lower limbSwell and ache etc., when serious, cause ureteral obstruction, nephredema, finally cause uremia. Arrived disease latter stage, disappearing can appear in patientThin, anaemia, heating and cachexia.
4, check and diagnose
(1) inspection of cervical carcinoma
Comprise general physical checkup and gynecologial examination. When gynecologial examination, can find that cervical carcinoma position is harder, easily hemorrhage, and should noteThere is absence of vagina to shift, answer lay special stress on to do three to close and examine (in abdominal touch, vagina, examine with anus in examine), understand rear, uterus and palaceSide has or not metastasis of cancer, uses definite extent of disease, carries out clinical stages.
Cervical carcinoma symptom after Ib phase and II phase is obvious, makes diagnosis by gynecologial examination and cervical biopsy.
0 phase and Ia phase symptom and sign are often not obvious, easy to cause missed diagnosis.
The prognosis of 0 phase and Ia phase taking the latter as good, should be paid attention to its early diagnosis far beyond the Ib phase.
(2) method of early diagnosis of cervical carcinoma
The all chance doubtful cases of cytolgical examination, as uterine neck contact bleeding or rotten to the corn heavier, obstinate person, should make uterine neckScraping blade is looked into oncocyte. As find further row cervical biopsy of cancer cell or dyskaryotic cell. When cervical cancer screening, adopt this moreMethod is screened cervical biopsy.
Iodine test is drawn materials in the district of being unstained, and can improve accuracy, while drawing materials, should comprise outside uterine neck squama post epithelium boundary, andFortunately do 4 biopsies at 3,6,9,12, in case fail to pinpoint a disease in diagnosis.
Vaginoscopy gynecatoptron can amplify uterine neck 16~40 times, can more carefully observe the change of epithelium of cervix uteri, andCan see squama post epithelium intersection. Under gynecatoptron instructs, do biopsy, can improve accuracy. Can't see squama post epithelium intersectionTime, should scratch and scrape as cervical canal, will scrape thing and send disease inspection.
Uterine neck is made excisional cone by uterine neck cone biopsy. Preoperatively should first determine diseased region as gynecatoptron, also can do iodine examinationTest. Excision sample should do serial sectioning with except infiltrating carcinoma.
(3) antidiastole
Be not difficult with other tumours in uterus as the discriminating such as fibroid, carcinoma of uterine body according to every symptom and sign.
Fibroid:
1. menorrhalgia and intermenstrual flow: cervix tumor under mucous membrane particularly occurs.
2. pain: general pain is indistinct pain, unless fibroid under mucous membrane will be discharged in uterus itself, andCause uterine contractile.
3. pressure symptom: fibroid can be urged to bladder, ureter, blood vessel, nerve and intestines, and produces various shadowsRing the operation of these organs.
4. infertile: fibroid can have influence on structure and the endometrial operation of uterine cavity, implantation is difficult for. But alsoThere is the patient of fibroid, equally can become pregnant normally, produce normally.
Carcinoma of uterine body:
1. after colporrhagia menopause, there is vagina continuation or irregular bleeding; Not yet menopause person can have menorrhalgia orIrregular bleeding.
2. neoplasm a few patients has water sample or courageous and upright discharge opeing to increase in pathology in early days, when late period, concurrent necrosis was infected,Can there is ichor blood system secretion.
3. pain generally occurs over just late period, in the time that canal of uterine cervix is caused hematocele in uterine cavity or empyema by interstitial laser photocoagulation obstruction,Can occur inferior belly gas pain or cancer knurl to stimulate uterine contraction and cause pain, when late cancer infiltrates tub wall, can occur pain in waist and lower extremities.
5, prevention and treatment
At present after world's treatment of human cervical cancer, total five-year survival rate is 55.5%, wherein I phase 80.04%, II phase 58.9%,III phase 32.8%, IV phase 7.1%.
Recurrence in 1 year after the patient treatment of about half, 25% in Second Year recurrence, 5% recurrence afterwards in 5 years. Therefore, suffer fromPerson monthly checks once in latter 1 year planted agent for the treatment of, and every 2 months of Second Year checks once. Within every 6 months later, check once. At every turnAll should make detailed pelvioscopy and vaginal smear.
SL checks to early cervical carcinoma effective and low wound: a perspective multicenter study prompting, sentinel lymph node (letterClaim: SL) check and can show the extraordinary lymphatic drainage path of early cervical carcinoma or detect metastasis of cancer, and avoid SL negative patient to enterThe unnecessary lymph node of row is removed.
128 routine IA1~IB1 phase Patients with Cervical Cancers are included in this research in. Extraordinary position SL refers to the pouring beyond sacroiliac region territoryFawn on. ITC), micrometastasis and the definition obviously shifted be respectively focus < 0.2mm, 0.2~2mm monoma cell (is called for short:With > 2mm.
Result shows, in 98.4% patient, SL detected. Extraordinary position 37.5% patient detects at least oneIndividual SL. In 16.4% patient, detect 26 positive SL, wherein 38% is obviously to shift, and 33% is micrometastasis, and 29% isITC; 27% can only detect by Immunohistochemical Method. In the patient's (81.2%) who shifts without SL, do not find false negative result.
(1) principle of reatment
The processing of cervix cancer divides atypical hyperplasia, early invasive carcinoma under carcinoma in situ, mirror, the processing method of infiltrating carcinoma.
1. atypical hyperplasia: biopsy, as being slight atypical hyperplasia person, by inflammation processing, is followed up a case by regular visits to scraping blade and necessity half a year temporarilyShi Zaizuo biopsy. Pathology continues constant person and can continue to observe. Be diagnosed as moderate atypical hyperplasia person, should be suitable for laser, freezing, electricPress. To severe atypical hyperplasia, the general row complete hysterectomies of advocating more. As an urgent demand fertility, also can be after excisional coneRegularly closely follow up a case by regular visits to.
2. carcinoma in situ: the general row complete hysterectomies of advocating, retain bilateral ovaries more; Also there is opinion to excise vagina 1 simultaneously~2cm person. The useful laser therapy of recent domestic, but must closely follow up a case by regular visits to after treatment.
3. early invasive carcinoma under mirror: general many opinions are done to expand complete hysterectomy, and the vagina tissue of 1~2cm. Because of mirrorThe possibility of lower early invasive carcinoma Lymph Node Metastasis is minimum, does not need to eliminate pelvic cavity lymphoid tissue.
4. infiltrating carcinoma: methods for the treatment of should be other according to the clinical phase, age and systemic conditions, and appointed condition. Conventional controlsTreatment method has radiation, operation and chemotherapy. Generally speaking, radiotherapy is applicable to each phase patient; The operation of Ib to IIa phaseCurative effect and radiotherapy are close; Adenocarcinoma of the uterine cervix is slightly poor to radiotherapy susceptibility, should take the complex treatment of operation excision plus radiotherapy.
(2) operative treatment
Adopt radical hysterectomy and pelvic lymph node to eliminate. Excision extension comprises full uterus, bilateral annex, vaginaStandby group lymph node in epimere and paracolpium and pelvic cavity (by cervix, in closed pore, ilium, outer, the total hypomere lymph node of ilium of ilium).Requirements of operation thoroughly, safety, strictly grasp indication, prevent complication.
(3) postoperative complication and processing
1. postoperative complication has that intraoperative hemorrhage, postoperative pelvic infection, lymphocyst, pool the Lushui River stay, urinary system infection contamination and defeatedUrethrovaginal fistula etc.
2. the processing of postoperative complication, in recent years, due to the improvement of operation method and anaesthesia technology, PAApplication, and the measure such as the outer negative pressure drainage of postoperative employing peritonaeum, the incidence of above-mentioned complication significantly reduces.
(4) radiotherapy
For the first-selected therapy of cervical carcinoma, can be applicable to each phase cervical carcinoma, radiation scope comprise cervix and the vagina of getting involved,Corpus uteri, the other tissue in palace and pelvic lymph node. Illuminating method is generally all taked with interior external exposure combination, and internal radiation is mainly for palaceNeck primary tumor and contiguous position thereof, comprise corpus uteri, portio supravaginalis and contiguous palace other tissue (" A ") point thereof. External exposure is mainRegion (" the B ") point that will distribute for pelvic lymph node. Internal source adopt radium in chamber (be called for short: Ra) or 137 caesiums (abbreviation:137Cs), mainly for uterine neck primary lesion. Outer radioactive source employing 60 brills (be called for short: 60Co), beyond primary lesionMET, comprise pelvic lymph node drainage district. Dosage is generally 60Gy. At present to the many opinions of early cervical carcinoma interior photograph in advancePenetrate. And to late cancer, particularly local Voluminously, hemorrhage active, or companion the infected is advisable with external exposure in advance.
III phase Randomized multicentre trial of the U.S. shows, with standard care (cisplatin chemotherapy add synchronize external exposure radiotherapy)Compare, gemcitabine+cis-platinum add synchronous external exposure radiotherapy (be called for short: XRT) sequential brachytherapy, be aided with gemcitabine again and add suitablePlatinum chemotherapy, can significantly improve the Clinical Outcome of local Advanced Cervical Carcinoma, but toxic and side effect also significantly increases.
This research is included 515 examples in and is not received chemotherapy and IIB~IVA phase cervical cancer patient of radiotherapy, and it is divided at randomTwo groups. A group: the sequential gemcitabine of cis-platinum 1 time weekly, continuous 6 weeks, the simultaneously sequential brachytherapy of row XRT (50.4Gy/28f)(30~35Gy), then be aided with gemcitabine and add cisplatin chemotherapy, 3 weeks × 2; B group: cis-platinum 1 time weekly, be used in conjunction 6 weeks, row XRT simultaneouslySequential brachytherapy (with A group).
Result demonstration, 3 years PFS of A group lead and are significantly higher than B group (74% pair 65%, P=0.029), OS (P=0.0224), extremelyThe tumour progression time (P=0.0008) also obtains significantly improves. But 3 grades of A groups or 4 grades of toxic reaction incidences are significantly higher than B group(86.5% pair 46.3%, P < 0.001).
(5) chemotherapy
Up to the present cervix cancer is insensitive to most of cancer therapy drugs, and the efficient of chemotherapy is no more than 15%, late periodPatient can adopt the complex treatment such as chemotherapy, radiotherapy. Chemotherapeutics can adopt 5-fluor-uracil, and adriamycin etc. carry out vein or partInjection.
In a word, existing technical data analysis shows, sesterterpenoids compound H ippolideJ is a new chemical combinationThing, researchs and develops the purposes of this sesterterpenoids compound H ippolideJ, further studies sesterterpene compoundsThe preparation technique of HippolideJ, improve the quality of products and clinical efficacy, can there is significant social benefit, economic benefit.
By literature search, up to the present, not yet find that there is the product of sesterterpenoids compound H ippolideJ aspectReport.
Summary of the invention
The technical problem that will solve required for the present invention be disclose a kind of sesterterpene compounds and preparation method thereof andPurposes, a kind of new sesterterpenoids compound H ippolideJ and its production and use, deposits to overcome prior artAbove-mentioned defect.
That is to say, the present invention is by the research such as zoopery, clinical testing and theory study, and one of object is intended to provideA kind of new sesterterpenoids compound H ippolideJ.
Two of object of the present invention is to provide a kind of preparation method of this sesterterpenoids compound H ippolideJ.
Another object of the present invention is the application aspect such as clear and definite sesterterpenoids compound H ippolideJ is antitumorActivity, contains the pharmaceutical composition of above-mentioned sesterterpenoids compound H ippolideJ as sides such as the antitumor products of preparationThe application of face, the namely purposes of sesterterpenoids compound H ippolideJ. In said composition, two sesquialters of the present inventionTerpenoid HippolideJ accounts for 10%~90% (percentage by weight), preferably accounts for 50%~90% (percentage by weight).
(1) definition of the present invention
Antitumor product of the present invention refers to and is directly used in prevention, diagnosis, detection, protection, treatment and research tumourAnd one or more in the product of directly related disease, comprise a kind of or many in anti-lung cancer product or anti-cervical cancer productKind; Described tumour is to comprise one or more in lung cancer or cervical carcinoma.
Anti-lung cancer product of the present invention refers to and is directly used in prevention, diagnosis, detection, protection, treatment and research lung cancerAnd one or more in the product of directly related disease, described lung cancer refers in non-small cell lung cancer and ED-SCLCOne or more, described non-small cell lung cancer is to comprise one or more in phosphorus cancer, gland cancer or maxicell lung cancer.
Anti-cervical cancer product of the present invention refers to and is directly used in prevention, diagnosis, detection, protection, treatment and research palaceOne or more in the product of neck cancer and directly related disease thereof, described cervical carcinoma is under atypical hyperplasia, carcinoma in situ, mirrorOne or more in early invasive carcinoma or infiltrating carcinoma.
Antitumor product of the present invention is all to comprise one or more in medicine, Foods or drinks field product,One or more in preferred agents, reagent, food, health food, additive or beverage, further preferred agents, reagent, foodOne or more in product or beverage etc., most preferably medicine.
The medicinal raw material that sesterterpenoids compound H ippolideJ of the present invention uses refers to sponge or spongeCrude extract, preferred Demospongiae (Demospongiae) sponge or Demospongiae (Demospongiae) sponge crude extract,One or more in Calcispongea (Calcarea) sponge or Calcispongea (Calcarea) sponge crude extract etc., enter oneWalk preferred sycon (Grantia) or sycon (Grantia) crude extract, Leucosolenia (Leucosolenia) or Leucosolenia(Leucosolenia) crude extract, bath sponge (Euspongiaofficinalis) or bath sponge (EuspongiaOfficinalis) crude extract, fine hair horse sponge (Hippospongialachne) or fine hair horse sponge (HippospongiaLachne) one or more in crude extract, fresh water sponges (Spongilla) or fresh water sponges (Spongilla) crude extract etc.;Preferred fine hair horse sponge (Hippospongialachne) or fine hair horse sponge (Hippospongialachne) crude extract againDeng in one or more.
Sesterterpenoids compound H ippolideJ prevents, diagnoses, detects, protects, treats and studies antineoplastic workProperty composition, its occupation mode is to comprise independent use or combine the one in use etc. with other chemical substances, preferably makes separatelyWith, all can be used in the antitumor product of preparation.
Test sample is all to take conventional preparation method to obtain, the sesterterpenoids compound H ippolide obtainingThe general < 60% of J content, but by purifying, can obtain the pure of sesterterpenoids compound H ippolideJ after purifyingDegree can be more than 95%, i.e. the defined sesterterpenoids compound H of the present invention ippolideJ.
That is to say, adopting sesterterpenoids compound H ippolideJ is raw material, or directly adopts and contain two timesThe sponge of half terpenoid HippolideJ is raw material, or directly adopts and contain sesterterpenoids compound H ippolideThe sponge crude extract of J is raw material, can both be directly or indirectly for the preparation of antitumor product. Sesterterpene compoundsIt is the defined sesterterpenoids compound H of the present invention ippolideJ that HippolideJ preferably uses with substantially pure form,As purity >=95% of sesterterpenoids compound H ippolideJ.
(2) technical conceive
Independent development original new drug is a current urgent task of China, and traditional Chinese medicine has a long history, and usesChemoprophylaxis and treatment disease aspect have also accumulated rich experience, therefore particularly find ocean and have from existing natural resourcesThe active component of effect or find that its new purposes is all effective quick approach is also that the advantage of Chinese original new drug development is with fastThe place of prompt approach.
Marine organisms are one of valuable sources of pharmaceuticals industry always, are also study hotspots in recent years. Ocean approximatelyTake up an area 71% of ball surface area, microbial resources are richly stored with. Along with continually developing of marine resources, find new oceanBiological or to screen the difficulty of new active component increasing, and resistance to the action of a drug problem is day by day serious, make marine organisms sourceNew drug development is faced with severe challenge. But increasing research shows in recent years, marine organisms---especially those are with seaThere is the biology of the relation such as symbiosis or parasitism in ocean microorganism---and can produce structure metabolism unique and the strong physiologically active of tool and produceThing, has broad application prospects. Scientists is estimated, is developed new marine drug and will place hope on this new neck of marine organismsTerritory. For example, sponge secondary metabolite is rich and varied, wherein contains and has in a large number antitumor, antiviral, antibacterial, anti-inflammatory and exempt fromThe different bioactive compounds such as epidemic disease adjusting are the focuses of marine nature products chemistry research always.
Inventor, by sponge extract being carried out to the chemical constitution study of system, screens and proves in this sponge extractNew sesterterpenoids compound H ippolideJ and activity and purposes, thus inventor infers sesterterpene compoundsHippolideJ, in the clinical drug effect of the aspect activity such as prevention, diagnosis, detection, protection, treatment and Effect of Anti tumour, also should leadIf by active site this sponge extract particularly the drug effect of sesterterpenoids compound H ippolideJ bring into play,Result of study also prove and confirmed this sponge extract particularly sesterterpenoids compound H ippolideJ have significantlyPharmacologically active.
Inventor through the latest find of research is: sesterterpenoids compound H ippolideJ can antitumor gradeNew role.
The diseases such as tumour have a strong impact on health and the life quality of Chinese population, and development prevents, diagnoses, detects, protects, controlsTreat and product, particularly medicine, diagnostic reagent and the health products etc. of the aspects such as Effect of Anti tumour, have significant social benefit,Economic benefit.
According to this idea and thinking, inventor, by experimental study and analysis repeatedly, successfully obtains sesterterpenoidsCompound H ippolideJ and corresponding application product thereof.
(3) structure and properties of sesterterpenoids compound H ippolideJ
Table 1, HippolideJ's1H and13C nuclear magnetic resonance data table
The present invention to sesterterpenoids compound H ippolideJ at prevention, diagnosis, detection, protection, treatment and Effect of AntiMany-sided test and study has been carried out in the aspects such as tumour.
The invention provides a kind of new sesterterpenoids compound H ippolideJ being separated to from sponge, its chemistryStructural formula is as follows:
Structural Identification is as follows:
Routinely through various modern spectral techniques such as NMR, HRESIMS, CD, IR, and the change such as recrystallization, Mosher reactionChemical constitution and the spatial configuration of method HippolideJ, its absolute configuration is 4S, 5R, 10S, 11R. Physicochemical data: colourlessGrease;
Ir data: vmax3439,2927,1749,1448,1379,1144,1041,887cm-1
High resolution mass spectrum provides molecular ion peak m/z407.2563[M+Na]+, infer that molecular formula is C25H36O3
1HNMR(CDCl3, 500MHz) and13CNMR(CDCl3, 125MHz) and data are in table 1.
(4) preparation method of sesterterpenoids compound H ippolideJ
The present invention provides following technical scheme according to above-mentioned technical conceive and result of study:
The preparation method of the compounds of this invention HippolideJ is as follows:
(1) prepare sponge extract medicinal extract
1. freezing sponge is chopped into fritter, with ethanol diacolation extraction routinely, obtains extract;
2. by extract reduced pressure concentration, obtain extract medicinal extract;
Described sponge is to comprise Demospongiae (Demospongiae) sponge, Calcispongea (Calcarea) spongeDeng in one or more, further preferably sycon (Grantia), Leucosolenia (Leucosolenia), bath sponge(Euspongiaofficinalis), fine hair horse sponge (Hippospongialachne), fresh water sponges (Spongilla) etc.In one or more; Preferred fine hair horse sponge (Hippospongialachne) again.
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate, concentrated extract obtains fat-solubleMedicinal extract; Fat-soluble medicinal extract is suspended in methanol solution, and with non-polar organic solvent extraction, concentrated extract obtains nonpolarly havingMachine solvent extraction medicinal extract; Add water the methanol concentration of suspension is adjusted to 60%, with dichloromethane extraction, concentrated extract obtainsCarrene extracts medicinal extract; By initial water extracting n-butyl alcohol, concentrated that n-butanol extracts medicinal extract;
Described methanol solution is 50%~95% methanol solution, preferably 80%~95% methanol solution, further90% methanol solution;
Described non-polar organic solvent is to comprise one or more in benzinum, ether or benzene etc., preferably benzinumOr one or more in ether etc., further preferred benzinum;
2. carrene is extracted to medicinal extract through decompression column chromatography, with carrene: methyl alcohol=100: 1,50: 1,30: 1,20:Be solvent gradient elution at 1,10: 1,5: 1,1: 1, and according to TLC, colour developing merges similar stream part, obtains 9 component Fr.1~Fr.9;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50: 1,20: 1,10: 1,5: 1,1: 1 be solvent gradient elution at 3: 1, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtainTo the noval chemical compound HippolideJ of sesterterpenoids.
(5) pharmacologically active of sesterterpenoids compound H ippolideJ
Anti tumor activity in vitro experiment
Compound H ippolideJ of the present invention has been carried out to Cytostatic to tumor cell test, and test method adopts normalThe mtt assay of rule.
1, tumor cell line: A549 (human lung carcinoma cell), Hela (human cervical carcinoma cell), by the biological limited public affairs of Shanghai Tian JiaDepartment provides;
2, experiment reagent, consumptive material and instrument: DMSO and MTT (sigma company), culture dish, pipette and 96 orifice plates(Corning company);
3, experimental drug: compound H ippolideJ is prepared by embodiment;
4, cell is cultivated
4 strain cell HCT116, SW480, SGC7901, the Hela warp routinely of exponential phase will be grown in respectively0.01% trypsinization, adjusts cell density to 2.0 × 103Individual/hole, is inoculated in respectively 96 orifice plates with every hole 100 microlitres, will4 96 orifice plates are placed in 5%CO237 DEG C of overnight incubation in incubator.
Table 2, the HippolideJ half effective inhibition concentration (μ M) to tumour cell
5, cell viability test experience
Every 96 orifice plates are established 8 groups, i.e. positive controls, negative control group, 6 concentration groups of medicine. Positive control drug isAdriamycin, is mixed with the solution that concentration is 0.4 grams per milliliter with DMSO, by experimental drug thing plakortoneH orIt is that the medicine of 100,50,25,12.5,6.5,3.125 (ug/ml) is molten that plakortoneJ is mixed with respectively concentration with DMSOLiquid, joins the drug solution of variable concentrations (20 microlitre) respectively in 96 orifice plate corresponding apertures, and negative control group adds equal-volumeDMSO, positive controls adds adriamycin solution 20 microlitres, and each concentration is established three multiple holes, at 5%CO2Training in 37 DEG C of incubatorsSupport 72 hours, every hole adds the MTT of the 5mg/ml of 20 microlitres, continues at 37 DEG C and hatches 3 hours, sucks the solution in hole, more everyHole adds the DMSO of 100 microlitres to dissolve, and uses SpectraMAX340 ELIASA to detect absorbance value L1 in wavelength 550nm, inReference wavelength 690 nanometer detection absorbance value L2, (are called for short the poor of absorbance value: L1-L2) inhibitor variable concentrations is doneFigure, taking sigmoidaldose-response (varibleslope) as models fitting, application software GraphpadPrism4Calculate IC50, the results are shown in Table 2.
Above-mentioned experimental result shows: compound H ippolideJ all shows bright to above-mentioned two kinds of different tumor cell linesAobvious inhibitory action, therefore can be for the preparation of anti-lung cancer product or anti-cervical cancer product.
(6) purposes of sesterterpenoids compound H ippolideJ
1, general introduction
The object of this invention is to provide a kind of for prevention, diagnosis, detection, protection, treatment and Effect of Anti tumour and straightConnect the product of relevant disease, comprise one or more in medicine, reagent, food etc., preferred agents.
Prove by Pharmacological Activity Screening, sesterterpenoids compound H ippolideJ is its prevention, diagnosis, detection, guarantorProtect, the active site for the treatment of and Effect of Anti tumour and directly related disease thereof.
Antitumor activity in vitro shows, compound H ippolideJ is to human lung cancer cell A549, human cervical carcinoma cell HelaAll show and suppress active, therefore can be used for preparing antineoplastic.
The present invention, for development antineoplastic provides new lead compound, is exploitation Chinese Sea medicine resourceScientific basis is provided.
Show through experimental study, sesterterpenoids compound H ippolideJ is external can significantly delay relevant diseaseDevelopment. Completed acute toxicity testing proves, mouse stomach administration exceedes 1.0g/ to the maximal tolerance dose of this active siteKg, is equivalent to the more than 200 times of clinical recommended drug dosage, shows that this active component is safe and reliable, has solved in Chinese medicine compound prescriptionLow and the problem that contains toxic component of complicated component, active constituent content.
In sum, inventor has carried out theory study to sesterterpenoids compound H ippolideJ, through a large amount ofParticularly long-term pharmacology test of experimental study, finds that the sesterterpenoids compound H ippolideJ addressing has significantlyThe activity of prevention, diagnosis, detection, protection, treatment and Effect of Anti tumour and directly related disease thereof.
Therefore, sesterterpenoids compound H ippolideJ and composition thereof can be used for preparing antitumor product, preferably withSesterterpenoids compound H ippolideJ of the present invention is the medicine that raw material is prepared from.
2, the using method of sesterterpenoids compound H ippolideJ and composition thereof and requirement
Sesterterpenoids compound H ippolideJ of the present invention can combine use separately or with other active component, bagDraw together for the preparation of for preventing, diagnose, detect, protect, the product for the treatment of and Effect of Anti tumour and directly related disease thereof, compriseMedicine, reagent or food etc., especially medicine.
In concrete use, sesterterpenoids compound H ippolideJ of the present invention can use separately, exampleAs the form application with active site, its derivative or pharmaceutical salts, can also use together with other many chemical substances. No matterWhether these chemical substances have biologically active or have the function for the treatment of disease, comprise miscellaneous function as collaborative amplification,The side effects of antagonism or alleviation sesterterpenoids compound H ippolideJ etc., these chemical substances are to comprise pharmaceutically canOne or more in carrier, food, natural products, chemical synthetic drug or the mankind's medication etc. of accepting; Preferably include medicineOne or more in acceptable carrier or food etc.; Further preferred pharmaceutically acceptable carrier.
" pharmaceutically acceptable carrier " used herein comprises the applicable solvent of any and all physiology, disperses to be situated betweenOne or more in matter, afterbirth, antiseptic and antifungal agent, isotonic agent or absorption delay agent etc. Pharmaceutically acceptable yearThe example of body comprises in one or more water, salt solution, PBS, glucose, glycerine or ethanol etc. and composition thereofOne or more. In many cases, in said composition, preferably include isotonic agent, for example, sugar, such as sweet mellow wine, sorbOne or more in polyalcohol or the sodium chloride etc. of alcohol, sorbierite. Pharmaceutically acceptable carrier can also comprise a small amount ofAuxiliary substance, such as, in wetting agent or emulsifying agent, anticorrisive agent or buffer solution etc. one or more, they have strengthened this two sesquialterThe term of validity of terpenoid HippolideJ or effect.
From concrete classification, said pharmaceutically acceptable carrier refers to that the medicine of medicine and pharmacology field routine carriesBody, comprises lubricant, as one or more in talcum powder, polyethylene glycol or dolomol etc.; Disintegrant, as microcrystalline celluloseDeng; Filler, as one or more in starch, dextrin or lactose etc.; Adhesive, as pregelatinized starch, cellulose derivative,One or more in alginates, gelatin or polyvinylpyrrolidone etc.; Osmotic pressure regulator, as sodium chloride, glucose, sugarcaneOne or more in sugar, sorbierite or sweet mellow wine etc.; PH adjusting agent, a kind of in the acid such as example hydrochloric acid, NaOH or alkali orMultiple; Solvent, as in water, buffer solution, ethanol or propane diols etc. one or more etc.; Antioxidant and complexing agent, as sulfurous acidOne or more in sodium, EDTA etc.; Surfactant, as quaternary ammonium compound, hexadecanol etc.; Absorption carrier, as kaolinOr one or more in soap clay etc.; Macromolecular scaffold agent, as a kind of in cyclodextrin, polyethylene glycol, poloxamer etc. orMultiple; In addition, can also in composition, add other assistant agent, as the one in flavouring agent, anticorrisive agent or sweetener etc. or manyKind.
For example,, by active component sesterterpenoids compound H ippolideJ dissolving, suspendible or be emulsifiable in suitable water-basedFor example, in (, one or more in distilled water, physiological saline or Green's solution etc.) or oil-based solvent (for example, plant in solventOne or more in oil such as olive oil, sesame oil, cottonseed oil, corn oil or propane diols etc.) in, can make injection systemAgent, wherein can contain solubilizer (for example, polyoxyethylene sorbitan monoleate, Crodaret, PVP, cyclodextrin, pool in solventOne or more in Luo Shamu, polyethylene glycol, phenmethylol, chlorobutanol or phenol etc.), osmotic pressure regulator (for example, chlorinationOne or more in sodium, glycerine, D9-mannose, D-glucitol or glucose etc.). In this case, if necessary, canAdd additive, for example stabilizing agent (for example, human serum albumins etc.), anodyne (for example, procaine hydrochloride or lidocaineDeng in one or more) etc.
Of the present invention and sesterterpenoids compound H ippolideJ can also combine and make with the form of compositionWith, particularly with by other chemical substance animal especially mammal is comprised to people or other animals treat institute as medicineWith composition or similar composition. Described mammal, comprise people, mouse, rat, sheep, monkey, ox, pig, horse, rabbit,One or more in dog, chimpanzee, baboon, marmoset, macaque or rhesus macaque etc., preferably people, mouse, rat, monkey, pig, rabbit or dogDeng in one or more, further preferably one or more in people, rat or monkey etc. For example, can be by two times of the present inventionHalf terpenoid HippolideJ add be suitable for to curee's Pharmaceutical composition in. Conventionally this Pharmaceutical composition,Comprise sesterterpenoids compound H ippolideJ of the present invention and pharmaceutically acceptable carrier.
The composition of sesterterpenoids compound H ippolideJ particularly pharmaceutical composition can have various forms, bagDraw together one or more in the dosage forms such as such as liquid, semisolid and solid; Wherein said pharmaceutical composition comprises treatmentThe sesterterpenoids compound H ippolideJ of effective dose is active component, and one or more are pharmaceutically acceptableCarrier.
Sesterterpenoids compound H ippolideJ of the present invention or its pharmaceutical composition can adopt abilityThe known conventional production method in territory is made any formulation that is suitable for experiment, research or applies clinically, comprises solid systemAgent is as capsule, tablet, granular preparation etc., and liquid preparation is as oral liquid or injection etc.
For example make active component mix with one or more carriers, be then made into required formulation. Described formulationComprise one or more in tablet, capsule, granule, supensoid agent, emulsion, solution, syrup or injection etc., takeOral or injection (comprise in intravenous injection, drip-feed, intramuscular injection or hypodermic injection etc. one or more), mucous membrane dialysisDeng in one or more methods of administration carry out prevention, diagnosis, detection, protection, the treatment of antitumor and directly related diseaseOr scientific research.
It is 0.5%~99% active component sesterterpene compounds that pharmaceutical composition preferably contains weight ratioHippolideJ, further preferably contains weight ratio and is 1%~95% active component sesterterpene compoundsHippolideJ, most preferably contains weight ratio and is 5%~90% active component sesterterpenoids compound H ippolideJ.
The pharmaceutical composition of sesterterpenoids compound H ippolideJ generally must be aseptic and be being produced under condition of storageStable. Said composition can be mixed with to solution, microemulsion, dispersion liquid, liposome or other is suitable for having of high drug concentrationOrder structure. By by a kind of of this sesterterpenoids compound H ippolideJ of aequum and required mentioned component or combinationAdd together in suitable solvent and then carry out aseptic filtration and prepare aseptic parenteral solution. Generally speaking, by by this two sesquialterTerpenoid HippolideJ adds in the aseptic solvent that contains basic decentralized medium and required above-mentioned other composition and preparesDispersion liquid. In the case of the sterile powder for the preparation of aseptic parenteral solution, the preparation method of recommendation is vacuum drying and freezingDrier. For example, by the dressing such as lecithin, the dispersion liquid in the situation that by keeping required granular size and by makingWith surfactant, can keep the adequate liquidity of solution.
In said composition, can comprise the medicament that postpones absorption, for example Monostearate or gelatin, to reach injectable compositionProlongation absorb; Can comprise high molecular polymer carrier, as HPMC or polyoxyethylene, to reach Orally administered compositionProlongation discharge.
During for patient, sesterterpenoids compound H ippolideJ dosage of the present invention is 20~50mg/kgD, can use one or more times, and this dosage or consumption are conventionally according to patient or user's age and body weight and health shapeThe situation of condition or patient's symptom decides.
Sesterterpenoids compound H ippolideJ of the present invention and Pharmaceutical composition thereof can comprise " treatment effective dose " orThe sesterterpenoids compound H ippolideJ of the present invention of " prevention effective dose ". " treatment effective dose " refers at necessary dosageWith the amount that effectively reaches required result for the treatment of under the time. The treatment effective dose of sesterterpenoids compound H ippolideJ canAccording to the patient's condition such as individual, age, sex and body weight and this sesterterpenoids compound H ippolideJ at this individualityCause the factors such as the ability of required reaction and change. Treatment effective dose also refers to this sesterterpenoids compound H ippolideJ'sUseful result for the treatment of exceedes the amount of its any toxicity or harmful effect.
" prevention effective dose " refers to the amount that effectively reaches required preventive effect under necessary dosage and time. Because prophylacticAmount is for the ill front or early stage curee of disease, and prevention effective dose is less than treatment effective dose conventionally. Sesterterpene of the present inventionThe typical non-limiting scope of the treatment of compounds HippolideJ or prevention effective dose is 20~50mg/kg, more preferablyBe 30~40mg/kg. It should be noted that dose value will change according to the disease type of wanting to alleviate and seriousness, that is to say for suffering fromWhen person, sesterterpenoids compound H ippolideJ dosage of the present invention or consumption, conventionally according to patient or userThe situation of age and body weight and health or patient's symptom decides.
In addition, it should be understood that for any specific curee, should along with the time according to individual need and give with or supervision giveAdjust given dose system with the people's of described composition professional judgement, and the dosage range of setting is only illustrative herein, can't limit scope or the practice of claimed composition.
That is to say, need to, according to object, method of administration, disease and the situation etc. for the treatment of for the treatment of, change the present invention twoDosage or the consumption of the each and/or every day of sesquiterpenoids HippolideJ. For example, give mammal through vein,Especially adult (as body weight 60kg), the single dose of described sesterterpenoids compound H ippolideJ is about 110~1600mg, preferred about 200mg, preferably administration every day 1~3 time. Can adjust dosage unit, to put forward the best required reaction (example of archAs, treatment or prevention are replied).
For example, can single-bolus high-dose administration, can within a period of time, give several divided doses or according to treatment situationUrgency reduce in proportion or increase dosage. Preparation is easy to the non-enteron aisle combination of administration and the unified dosage unit form of dosageThing is especially favourable. Dosage unit form used herein, refers to be suitable for the dosage unit of the mammalian subject of wish treatmentPhysical separation unit; The calculating that each unit contains scheduled volume is for together producing required result for the treatment of with required pharmaceutical carrierActive matter sesterterpenoids compound H ippolideJ. The specification of dosage unit form of the present invention, is determined by the following and directlyDepend on the specific characteristic of following (a) this sesterterpenoids compound H ippolideJ and particular treatment or the prevention of wanting to reachEffect, and (b) mix in this technology that is used for the treatment of individual sensitivity sesterterpenoids compound H ippolideJ inIn restriction.
3, the pharmaceutical dosage form of sesterterpenoids compound H ippolideJ and composition thereof and method of administration
Sesterterpenoids compound H ippolideJ of the present invention and composition thereof prepare for prevention, diagnosis,The product of detection, protection, treatment and Effect of Anti tumour and directly related disease thereof, wherein according to beverage, food technology fieldRequire the product of preparation to can be used in prevention, protect and treat antitumor and directly related disease; According to medical technical fieldThe product prepared of requirement can be used in patient's treatment or health care, can either be directly used in separately the medicine of preparation treatment or health careThing, also can mix or combine with many chemical substances, directly or indirectly for the preparation of the medicine for the treatment of or keeping healthy. HereDescribed chemical substance and this section are above described identical.
In the present invention, required material comprises raw material of the present invention, above-mentioned matching used chemical substance etc., all should basisActual conditions and needs, the material of employing food stage or pharmaceutical grade.
Sesterterpenoids compound H ippolideJ of the present invention and composition thereof, can be with known in the artThe whole bag of tricks administration, although method of administration/administering mode of recommending in many therapeutical uses is spray or oral administration. ButThat technical staff will appreciate that method of administration/administering mode changes with required result. In some concrete enforcement, this activityCompound can with this compound of protection avoid the carrier that discharges fast together preparation example as empty release formulation, comprise that graft transmitsSystem, transdermal paste one or more in transmission system or micro-capsule transmission system etc. In addition, can also use biodegradable, biocompatible polymer, for example ethylene-ethyl acetate, polyanhydride, polyglycolic acid, collagen, polyorthoesters or PLADeng in one or more. Prepare the equal patent applied for of many methods of this preparation or generally known to those skilled in the art(for example SustainedandControlledReleaseDrugDeliverySystems, J.R.Robinson edits,MarcelDekker, Inc., New York, 1978).
In sesterterpenoids compound H ippolideJ of the present invention or its pharmaceutical composition, can be containing capableThe known pharmaceutically acceptable carrier in territory and other optional member. Carrier comprises CMS, starch, cellulose, brightGlue, sodium acid carbonate, propane diols or Tween 80 etc. Optional member is for example colouring agent, sweetener, antioxidant etc.
Sesterterpenoids compound H ippolideJ of the present invention and composition thereof, conventionally by oral, rectum orOne or more modes in parenteral etc., are applied to the patient who needs this treatment.
Sesterterpenoids compound H ippolideJ of the present invention, its derivative or pharmaceutical salts, composition are particularlyPharmaceutical composition can be made any formulation that is suitable for applying clinically, comprises solid pharmaceutical preparation, as capsule, tablet,Grain preparation etc., semisolid preparation is as ointment etc., and liquid preparation is as oral liquid, supensoid agent, emulsion etc., or injection. Take mouthClothes or injection (comprise in intravenous injection, drip-feed, intramuscular injection or hypodermic injection etc. one or more), mucous membrane dialysis etc.In one or more methods of administration carry out antitumor and directly related disease prevention, diagnosis, detection, protection, treatment orScientific research.
When oral, can be made into conventional solid pharmaceutical preparation as a kind of in tablet, pulvis, granula or capsule etc. orMultiple. Implement time, sesterterpenoids compound H ippolideJ of the present invention can with for example inert diluent or assimilableEdible carrier is together oral. This sesterterpenoids compound H ippolideJ (with common its composition, if needed) can also be wrapped inHard or soft shell gelatin capsules, be pressed into tablet or directly add in curee's meals. About oral therapeutic administration, can be byDescribed sesterterpenoids compound H ippolideJ adds and with edible tablet, buccal tablet agent, lozenge, glue together with excipientOne or more forms in capsule, suspension, syrup or wafer etc. are used.
For to give sesterterpenoids compound H ippolideJ of the present invention outside parenterai administration, may need to useThe material that prevents its inactivation to this sesterterpenoids compound H ippolideJ dressing or with this sesterterpene compoundsHippolideJ together gives. Supplementary reactive compound can also be added in said composition. In the specific implementation, incite somebody to action thisInvention sesterterpenoids compound H ippolideJ and one or more other medicines that can be used for the treatment of disease are joined altogetherMake and/or give altogether. Thisly combine use, can utilize primely this medicine giving compared with low dosage, therefore avoidPossible toxicity or the complication relevant to various monotherapies.
Make liquid preparation as one or more in aqua, oil-suspending agent or other liquid preparation, as syrup, tincture orOne or more in elixir etc.; During for parenteral, solution, aqua or the oiliness that can be made into injection suspendOne or more in agent etc.
Above medicine or pharmaceutical composition can use various approach, and in described type of service, preferred form isOral formulations (as one or more in tablet, coated tablet, capsule, solution or suspension etc.), non-enteron aisle give formulation (asOne or more in injection, ointment or patch etc.) etc. in one or more, further preferred tablet, capsule or injectionOne or more in agent etc., the particularly preferably one in tablet or injection.
In addition the medicinal raw material that, sesterterpenoids compound H ippolideJ uses comprises sponge or sponge crude extractDeng being also directly used in separately for the preparation of prevention, diagnosis, detection, protection, treatment and Effect of Anti tumour in some casesAnd the product of directly related disease, also can mix or combine with many chemical substances, direct with the form of compositionOr indirectly for the preparation of for preventing, diagnose, detect, protect, the product for the treatment of and Effect of Anti tumour and directly related disease thereof.Chemical substance described here and this section are above described identical.
For example, the medicinal raw material that sesterterpenoids compound H ippolideJ uses comprises sponge or sponge crude extractDeng powder for the preparation of for the particularly various formulations of medicine of antitumor prevention, diagnosis, protection and treatment product, orThe powder that the medicinal raw material that sesterterpenoids compound H ippolideJ uses comprises sponge or sponge crude extract etc. is with relevantAuxiliary material for the preparation of for preventing, diagnose, detect, protect, the product for the treatment of and Effect of Anti tumour and directly related disease thereofEspecially the medicinal raw material that the various formulations of medicine, or sesterterpenoids compound H ippolideJ uses comprises seaThe powder of silk floss or sponge crude extract etc. with relevant for the preparation of prevention, diagnosis, detection, protection, treatment and Effect of Anti tumour andThe product of its directly related disease is if medicine is together for the preparation of swollen for prevention, diagnosis, detection, protection, treatment and Effect of AntiThe product of knurl and directly related disease thereof is as the various formulations of medicine, or sesterterpenoids platform thing HippolideJ instituteThe powder that the medicinal raw material using comprises sponge or sponge crude extract etc. and relevant ancillary drug are together for the preparation of in advanceThe product of anti-, diagnosis, detection, protection, treatment and Effect of Anti tumour and directly related disease thereof is as the various formulations of medicine, as sheetOne or more in agent, capsule or supensoid agent etc., preferably capsule.
One of described method is that the medicinal raw material that sesterterpenoids compound H ippolideJ is used comprises spongeOr the powder filling of sponge crude extract etc. is capsule, two of method is that sesterterpenoids compound H ippolideJ is madeWith the medicinal raw material powder that comprises sponge or sponge crude extract etc. with relevant for the preparation of prevention, diagnosis, detect, protection,Treatment and the product of Effect of Anti tumour and directly related disease thereof as filling together with medicine be capsule, three of method is by two timesThe powder that the medicinal raw material that half terpenoid HippolideJ uses comprises sponge or sponge crude extract etc. is with relevant auxiliaryHelping medicine filling is together capsule; Four of method is that the medicinal material that sesterterpenoids compound H ippolideJ is used is formerMaterial comprises that it is tablet that the powder of sponge or sponge crude extract etc. is directly pressed together according to a conventional method with relevant auxiliary material, five of methodThe powder that medicinal raw material that sesterterpenoids compound H ippolideJ is used comprises sponge or sponge crude extract etc.,The particularly medicine of product of other relevant antitumor and directly related diseases is straight according to a conventional method with relevant auxiliary material togetherConnect and press as tablet, six of method be medicinal raw material that sesterterpenoids compound H ippolideJ is used comprise sponge orIt is tablet etc. that the powder of sponge crude extract etc., relevant ancillary drug are directly pressed according to a conventional method with relevant auxiliary material together.
Except six kinds of above-mentioned basic skills, can also select sesterterpenoids compound H ippolideJ to useMedicinal raw material comprises other forms of sponge or sponge crude extract etc. or sesterterpenoids compound H ippolideJ is usedMedicinal raw material carry out after method processing well known in the art, for preparing various formulations contains sesterterpene compoundsThe product of the medicinal raw material that HippolideJ uses is as medicine. But, it should be noted that two times of above-mentioned direct usesWhen the medicinal raw material that half terpenoid HippolideJ uses comprises sponge or sponge crude extract etc., first basisThe dosage requirement of the sesterterpenoids compound H ippolideJ using, converts and obtains the sesterterpenoids of required useThe medicinal raw material that compound H ippolideJ uses comprises the consumption of sponge or sponge crude extract etc.
In sum, sesterterpenoids compound H ippolideJ of the present invention and composition thereof can be used for prevention, diagnosis,The product of detection, protection, treatment and Effect of Anti tumour and directly related disease thereof, preferred agents and food, further preferred medicineThing.
(7) technology speciality
The present invention provides a kind of new product for diseases such as prevention, diagnosis, detection, protection, treatment and Effect of Anti tumoursParticularly medicine source of sesterterpenoids compound H ippolideJ, thus existing antitumor system has been carried out improvement, changedBe apt to and improve.
The present invention is safe and effective, and practicality is stronger, and its preparation technology is easy, inexpensive, and easily operation, convenient and swift, usesEasy, evident in efficacy, can be used for the treatment of prevention, diagnosis, detection, protection, treatment and study of various radiation disease and assist and controlTreat.
The present invention studies sponge targetedly, has found a kind of new sesterterpenoids compound H ippolideJ, doesGone out beyond thought achievement, it uses safety, has brought into play to greatest extent effect; Product property is stable, is suitable for industrialization rawProduce; The result for the treatment of of prevention, diagnosis, detection, protection, treatment and study of various disease is obvious, and the scope of application is wide especially, thereforeEasily apply, can have a tremendous social and economic benefits in the short period of time.
In a word, active adaption of the present invention modern medical service and the need of work of scientific research field and the needs of human nature service,The present invention, for research and development radioresistance provides new preparation source, has important valency to improving existing medical levelValue.
The present invention has expanded new medical usage to sesterterpenoids compound H ippolideJ, also for prevention, diagnosis,Detection, protection, treatment and Effect of Anti tumour and directly related disease thereof provide a kind of new medicament sources. Two times of the present inventionHalf terpenoid HippolideJ safety and low toxicity, pharmacological action is stronger, and its raw material sources are abundant, inexpensive, preparation technology's letterSingle, yield is high, can be used for preparing the product of prevention, diagnosis, detection, protection, treatment and Effect of Anti tumour and directly related disease thereofProduct.
The present invention studies sesterterpenoids compound H ippolideJ targetedly, and its pharmacological action is stronger, its useSafety, one-object-many-purposes, has brought into play effect to greatest extent; Sesterterpenoids compound H ippolideJ stable in properties, is usedThe quality of the pharmaceutical preparations of preparation is stable, is more suitable for the suitability for industrialized production of antitumor product; Prevent, diagnose, detect, protect, treat and grindStudy carefully the successful of antitumor and directly related disease, and the scope of application is wide especially, therefore easily applies, can beIn the short time, have a tremendous social and economic benefits.
In a word, active adaption of the present invention modern medical service and the need of work of scientific research field and the needs of human nature service,The present invention provides new source for researching and developing new antitumor product, and the medicinal marine resources that develop China are hadImportant value, be for preventing, diagnose, detect, protect, the peace for the treatment of and the aspect such as Effect of Anti tumour and directly related disease thereofFull raw material.
Detailed description of the invention
The present invention has studied existing sesterterpenoids compound H ippolideJ preparation, provides a kind of new two timesHalf terpenoid HippolideJ, is convenient to the convenient of medical industry and safe handling.
Taking fine hair horse sponge as example, briefly set forth the preparation method of the compounds of this invention HippolideJ below
(1) prepare sponge extract medicinal extract
1. prepare extract:
Freezing sponge is chopped into fritter, and with 95% ethanol percolation extraction 6 times, each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains liposolubleProperty medicinal extract. Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtains oilEther position medicinal extract; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extract obtainsCarrene position medicinal extract. By extracting n-butyl alcohol 3 times of initial water, the concentrated n-butanol portion medicinal extract that to obtain.
2. carrene is extracted to medicinal extract 100g through decompression column chromatography, with carrene: methyl alcohol=50: 1,25: 1,15: 1,5: 1,1: 1 be solvent gradient elution at 2: 1, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging.
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50: 1,20: 1,10: 1,5: 1,1: 1 be solvent gradient elution at 3: 1, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtainTo compound H ippolideJ.
Taking several typical formulations as example, elaborate the various formulations of sesterterpenoids compound H ippolideJ belowConcrete preparation method.
The present invention prepares powder-injection and generally adopts conventional freeze-drying, using water as solvent, the steps include: to get two timesHalf terpenoid HippolideJ, adds excipient, is dissolved in water, and adds active carbon, and filtration sterilization is filling, partly rolls plug,Freeze drying, lid is rolled in tamponade. Excipient used is selected from sweet mellow wine, gelatin hydrolysate, glucose, lactose or dextran etc.In one or more. Every bottle containing sesterterpenoids compound H ippolideJ10~100mg.
By the sesterterpenoids compound H ippolideJ water that obtains soluble in water sesterterpenoids compound H ippolideJSolution, is dissolved in the tert-butyl alcohol obtaining phospholipid solution by phosphatide and Span80, then two solution is mixed to composition eutectic mixtures,Freeze drying, except desolventizing, obtains sesterterpenoids compound H ippolideJ compound, by sesterterpene compoundsHippolideJ fat complexes is dissolved in oil phase, if added with polyalcohol, is together dissolved in oil phase with phosphatide complexes, to obtain final productSesterterpenoids compound H ippolideJ oil solution.
The present invention prepares powder-injection also can adopt spray drying process, using water as solvent, the steps include: to get sesterterpenoidsCompound H ippolideJ, adds or does not add excipient (excipient is the same), is dissolved in water, and adds active carbon, filtration sterilization, sprayMist is dry, and aseptic subpackaged, lid is rolled in tamponade. Every bottle containing sesterterpenoids compound H ippolideJ10~100mg.
When the present invention prepares small-volume injection, using water for injection as solvent, preparation, also can add appropriate amount of auxiliary materials, and auxiliary material is selected fromOne or more in ethanol, propane diols, glycerine, polyethylene glycol, Ergol or dimethylacetylamide etc. Every containing two timesHalf terpenoid HippolideJ10~100mg.
The present invention prepares the transfusion of glucose infusion liquid or sodium chloride, using water for injection as solvent, add appropriate glucose orSodium chloride preparation, also can add appropriate amount of auxiliary materials, auxiliary material be selected from ethanol, propane diols, glycerine, polyethylene glycol, Ergol orOne or more in dimethylacetylamide etc. Every bottle containing sesterterpenoids compound H ippolideJ10~100mg.
The present invention prepares the oral formulations such as tablet, capsule, granule, oral liquid, auxiliary material can be lactose, starch, dextrin,Stearate etc., technology preparation routinely.
The present invention is preferably prepared into sesterterpenoids compound H ippolideJ and applies, and enumerates embodiment below and entersRow further illustrates.
In the present invention, the embodiment of above-described detailed description of the invention and the following stated is all in order to set forth betterThe present invention is not for limiting scope of invention. Below by embodiment, the present invention is described in detail.
Embodiment 1,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 1500mg phosphatide and be dissolved in 2mlIn the tert-butyl alcohol, mix and blend 30min, freeze drying, is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCapmulMCM) in and get final product.
Embodiment 2,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsMigyol812) in and get final product.
Embodiment 3,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCapmulMCM) and in the mixed solvent of propane diols (5: 5) and get final product.
Embodiment 4,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCapmulMCM) and in the mixed solvent of propane diols (7: 3) and get final product.
Embodiment 5,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCapmulMCM) and in the mixed solvent of propane diols (9: 1) and get final product.
Embodiment 6,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCapmulMCM) and in the mixed solvent of glycerine (5: 5) and get final product.
Embodiment 7,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCapmulMCM) and in the mixed solvent of glycerine (7: 3) and get final product.
Embodiment 8,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsGTCC) in and get final product.
Embodiment 9,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsGTCC) and in the mixed solvent of propane diols (5: 5) and get final product.
Embodiment 10,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsGTCC) and in the mixed solvent of propane diols (7: 3) and get final product.
Embodiment 11,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsGTCC) and in the mixed solvent of propane diols (9: 1) and get final product.
Embodiment 12,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsGTCC) and in the mixed solvent of glycerine (5: 5) and get final product.
Embodiment 13,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying powder is dissolved in 1ml medium-chain fatty glyceride and glycerine (choosing by freeze dryingWith GTCC) mixed solvent in (7: 3) and get final product.
Embodiment 14,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan85 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCaptex300) in and get final product.
Embodiment 15,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan85 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCaptex300) and in the mixed solvent of propane diols (5: 5) and get final product.
Embodiment 16,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan85 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCaptex300) and in the mixed solvent of propane diols (7: 3) and get final product.
Embodiment 17,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan85 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCaptex300) and in the mixed solvent of propane diols (9: 1) and get final product.
Embodiment 18,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan85 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCaptex300) and in the mixed solvent of glycerine (5: 5) and get final product.
Embodiment 19,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan85 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml medium-chain fatty glyceride by freeze drying powder and (selectsCaptex300) and in the mixed solvent of glycerine (7: 3) and get final product.
Embodiment 20,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 1500mg phosphatide and be dissolved in 2mlIn the tert-butyl alcohol, mix and blend 30min, freeze drying, is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects oilAcid glyceride) in and get final product.
Embodiment 21,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects oliveOil) in and get final product.
Embodiment 22,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects oleic acidGlyceride) and the mixed solvent of propane diols in (5: 5) and get final product.
Embodiment 23,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects oleic acidGlyceride) and the mixed solvent of propane diols in (7: 3) and get final product.
Embodiment 24,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects oleic acidGlyceride) and the mixed solvent of propane diols in (9: 1) and get final product.
Embodiment 25,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects oleic acidGlyceride) and the mixed solvent of glycerine in (5: 5) and get final product.
Embodiment 26,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan80 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects oleic acidGlyceride) and the mixed solvent of glycerine in (7: 3) and get final product.
Embodiment 27,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects bayAcid glyceride) in and get final product.
Embodiment 28,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects bayAcid glyceride) and the mixed solvent of propane diols in (5: 5) and get final product.
Embodiment 29,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects the moonCinnamic acid glyceride) and the mixed solvent of propane diols in (7: 3) and get final product.
Embodiment 30,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects bayAcid glyceride) and the mixed solvent of propane diols in (9: 1) and get final product.
Embodiment 31,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects bayAcid glyceride) and the mixed solvent of glycerine in (5: 5) and get final product.
Embodiment 32,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects bayAcid glyceride) mixed solvent in (7: 3) and get final product.
Embodiment 33,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects soybeanOil) in and get final product.
Embodiment 34,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects soybeanOil) and the mixed solvent of propane diols in (5: 5) and get final product.
Embodiment 35,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects soybeanOil) and the mixed solvent of propane diols in (7: 3) and get final product.
Embodiment 36,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects soybeanOil) and the mixed solvent of propane diols in (9: 1) and get final product.
Embodiment 37,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects soybeanOil) and the mixed solvent of glycerine in (5: 5) and get final product.
Embodiment 38,
Take 100mg sesterterpenoids compound H ippolideJ and be dissolved in 4ml water, take 300mg phosphatide and 150mgSpan20 is dissolved in the 2ml tert-butyl alcohol, and freeze drying is dissolved in 1ml long-chain fat acid glyceride by freeze drying powder and (selects soybeanOil) in mixed solvent (7: 3) and get final product.
One of preparation method of embodiment 39, compound L achninA
(1) prepare fine hair horse sponge extract medicinal extract
1. prepare extract
By fine hair horse sponge (Hippospongialachne) 3.6kg (dry weight) in freezing marine site, South China Sea XishaBe chopped into fritter, with 95% ethanol 20L diacolation extraction 6 times, each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 671g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains liposolubleProperty medicinal extract 246g. Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtainsPetroleum ether part medicinal extract 89g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extractionLiquid obtains carrene position medicinal extract 116g. By extracting n-butyl alcohol 3 times of initial water, the concentrated n-butanol portion medicinal extract that to obtain87g。
2. carrene is extracted to medicinal extract 116g through decompression column chromatography, with carrene: methyl alcohol=50: 1,25: 1,15: 1,5: 1,1: 1 be solvent gradient elution at 2: 1, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging.
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50: 1,20: 1,10: 1,5: 1,1: 1 be solvent gradient elution at 3: 1, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purifies with high efficiency liquid phase,Obtain 50.6mg compound H ippolideJ.
The preparation method's of embodiment 40, compound L achninA two
(1) prepare fresh water sponges extract medicinal extract
1. prepare extract
Freezing fresh water sponges (Spongilla) 3.6kg (dry weight) is chopped into fritter, carries with 95% ethanol 20L diacolationGet 6 times, each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 742g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains liposolubleProperty medicinal extract 255g. Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtainsPetroleum ether part medicinal extract 97g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extractionLiquid obtains carrene position medicinal extract 103g. By extracting n-butyl alcohol 3 times of initial water, the concentrated n-butanol portion medicinal extract that to obtain78g。
2. carrene is extracted to medicinal extract 103g through decompression column chromatography, with carrene: methyl alcohol=50: 1,25: 1,15: 1,5: 1,1: 1 be solvent gradient elution at 2: 1, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging.
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50: 1,20: 1,10: 1,5: 1,1: 1 be solvent gradient elution at 3: 1, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtainTo 42.3mg compound H ippolideJ.
The preparation method's of embodiment 41, compound L achninA three
(1) prepare bath sponge extract medicinal extract
1. prepare extract
Freezing bath sponge (Euspongiaofficinalis) 3.6kg (dry weight) is chopped into fritter, uses 95% secondAlcohol 20L diacolation extracts 6 times, and each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 748g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains liposolubleProperty medicinal extract 264g. Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtainsPetroleum ether part medicinal extract 99g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extractionLiquid obtains carrene position medicinal extract 135g. By extracting n-butyl alcohol 3 times of initial water, the concentrated n-butanol portion medicinal extract that to obtain78g。
2. carrene is extracted to medicinal extract 135g through decompression column chromatography, with carrene: methyl alcohol=50: 1,25: 1,15: 1,5: 1,1: 1 be solvent gradient elution at 2: 1, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging.
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50: 1,20: 1,10: 1,5: 1,1: 1 be solvent gradient elution at 3: 1, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtainTo 37.9mg compound H ippolideJ.
Embodiment 42, accelerated test and long-term stable experiment research
The sesterterpenoids compound H ippolideJ sample that utilizes the preferred embodiment of the invention to prepare, according to " changingLearn medicine stability investigative technique guideline " carry out accelerated test and long-term stable experiment research. Accelerated test and long-termStability test 12 months, measures the quality index such as its content, related substance, the results are shown in Table 3 and table 4 shown in.
Table 3, accelerated test result
Table 4, long-term test results
The preparation method's of embodiment 43, compound L achninA four
(1) prepare Leucosolenia extract medicinal extract
1. prepare extract: freezing Leucosolenia (Leucosolenia) 3.6kg (dry weight) is chopped into fritter, uses95% ethanol 20L diacolation extracts 6 times, and each diacolation 3 days, merges extract;
2. prepare extract medicinal extract: reduced pressure concentration said extracted liquid, obtains extract medicinal extract 693g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains liposolubleProperty medicinal extract 249g. Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtainsPetroleum ether part medicinal extract 94g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extractionLiquid obtains carrene position medicinal extract 128g. By extracting n-butyl alcohol 3 times of initial water, the concentrated n-butanol portion medicinal extract that to obtain78g。
2. carrene is extracted to medicinal extract 128g through decompression column chromatography, with carrene: methyl alcohol=50: 1,25: 1,15: 1,5: 1,1: 1 be solvent gradient elution at 2: 1, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging.
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50: 1,20: 1,10: 1,5: 1,1: 1 be solvent gradient elution at 3: 1, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtainTo 63.1mg compound H ippolideJ.
The preparation method's of embodiment 44, compound L achninA five
(1) prepare sycon (Grantia) extract medicinal extract
1. prepare extract: freezing sycon (Grantia) 3.6kg (dry weight) is chopped into fritter, with 95% ethanol 20LDiacolation extracts 6 times, and each diacolation 3 days, merges extract;
2. prepare extract medicinal extract: reduced pressure concentration said extracted liquid, obtains extract medicinal extract 739g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains liposolubleProperty medicinal extract 273g. Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtainsPetroleum ether part medicinal extract 102g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extractionGet liquid and obtain carrene position medicinal extract 146g. By extracting n-butyl alcohol 3 times of initial water, the concentrated n-butanol portion medicinal extract that to obtain91g。
2. carrene is extracted to medicinal extract 146g through decompression column chromatography, with carrene: methyl alcohol=50: 1,25: 1,15: 1,5: 1,1: 1 be solvent gradient elution at 2: 1, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging.
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50: 1,20: 1,10: 1,5: 1,1: 1 be solvent gradient elution at 3: 1, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtainTo 73.9mg compound H ippolideJ.

Claims (24)

1. sesterterpene compounds Hippolide J, is characterized in that, described sesterterpene compounds Hippolide J molecular formulaFor C25H36O3, there is following chemical structural formula:
2. the preparation method of sesterterpene compounds Hippolide J according to claim 1, is characterized in that, describedThe preparation method of sesterterpene compounds Hippolide J comprises the steps:
(1) prepare sponge extract medicinal extract
1. freezing sponge is chopped into fritter, with ethanol diacolation extraction routinely, obtains extract;
2. by extract reduced pressure concentration, obtain extract medicinal extract;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate, concentrated extract obtains fat-soluble medicinal extract;Fat-soluble medicinal extract is suspended in methanol solution, and with non-polar organic solvent extraction, concentrated extract obtains nonpolar organic moltenMedicinal extract is extracted in agent; Add water the methanol concentration of suspension is adjusted to 60%, with dichloromethane extraction, concentrated extract obtains dichloroMethane extracts medicinal extract;
2. carrene is extracted to medicinal extract through decompression column chromatography, with carrene: methyl alcohol=100:1,50:1,30:1,20:1,10:1,5:1,1:1 is solvent gradient elution, according to TLC, colour developing merges similar stream part, obtains 9 component Fr.1~Fr.9;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50:1,20:1,10:1,5:1,3:1,1:1 is solvent gradient elution, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtain twoThe noval chemical compound Hippolide J of sesquiterpenoids.
3. the preparation method of sesterterpene compounds Hippolide J according to claim 2, is characterized in that, describedSponge is one or more in Demospongiae (Demospongiae) sponge or Calcispongea (Calcarea) sponge.
4. according to the preparation method of the sesterterpene compounds Hippolide J described in claim 2 or 3, it is characterized in that, described inSponge be sycon (Grantia), Leucosolenia (Leucosolenia), bath sponge (Euspongiaofficinalis),One or more in fine hair horse sponge (Hippospongialachne) or fresh water sponges (Spongilla).
5. the preparation method of sesterterpene compounds Hippolide J according to claim 4, is characterized in that, describedSponge is fine hair horse sponge (Hippospongialachne).
6. the preparation method of sesterterpene compounds Hippolide J according to claim 2, is characterized in that, describedMethanol solution is 80%~95% methanol solution.
7. the preparation method of sesterterpene compounds Hippolide J according to claim 6, is characterized in that, describedMethanol solution is 90% methanol solution.
8. the preparation method of sesterterpene compounds Hippolide J according to claim 2, is characterized in that, describedNon-polar organic solvent is to comprise one or more in benzinum, ether or benzene.
9. the preparation method of sesterterpene compounds Hippolide J according to claim 8, is characterized in that, describedNon-polar organic solvent is to comprise one or more in benzinum or ether.
10. the preparation method of sesterterpene compounds Hippolide J according to claim 9, is characterized in that, describedNon-polar organic solvent is benzinum.
11. according to the preparation method of the sesterterpene compounds Hippolide J described in claim 1~10 any one, its featureBe, the preparation method of described sesterterpene compounds Hippolide J comprises the steps:
(1) prepare sponge extract medicinal extract
1. prepare extract:
Freezing sponge is chopped into fritter, and with 95% ethanol percolation extraction 6 times, each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains fat-soluble soakingCream; Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtains benzinum portionPosition medicinal extract; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extract obtains dichloroMethane position medicinal extract;
2. carrene is extracted to medicinal extract 100g through decompression column chromatography, with carrene: methyl alcohol=50:1,25:1,15:1,5:1,2:1,1:1 is solvent gradient elution, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50:1,20:1,10:1,5:1,3:1,1:1 is solvent gradient elution, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, changedCompound Hippolide J.
The preparation method of 12. sesterterpene compounds Hippolide Js according to claim 11, is characterized in that, described inThe preparation method of sesterterpene compounds Hippolide J comprise the steps:
(1) prepare fine hair horse sponge extract medicinal extract
1. prepare extract
Fine hair horse sponge (Hippospongialachne) the dry weight 3.6kg in freezing marine site, South China Sea Xisha is chopped intoFritter, with 95% ethanol 20L diacolation extraction 6 times, each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 671g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains fat-soluble soakingCream 246g; Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtains oilEther position medicinal extract 89g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extract obtainsTo carrene position medicinal extract 116g;
2. carrene is extracted to medicinal extract 116g through decompression column chromatography, with carrene: methyl alcohol=50:1,25:1,15:1,5:1,2:1,1:1 is solvent gradient elution, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50:1,20:1,10:1,5:1,3:1,1:1 is solvent gradient elution, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtain50.6mg compound Hippolide J.
The preparation method of 13. sesterterpene compounds Hippolide Js according to claim 11, is characterized in that, described inThe preparation method of sesterterpene compounds Hippolide J comprise the steps:
(1) prepare fresh water sponges extract medicinal extract
1. prepare extract
Freezing fresh water sponges (Spongilla) dry weight 3.6kg is chopped into fritter, with 95% ethanol 20L diacolation extraction 6 times,Each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 742g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains fat-soluble soakingCream 255g; Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtains oilEther position medicinal extract 97g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extract obtainsTo carrene position medicinal extract 103g;
2. carrene is extracted to medicinal extract 103g through decompression column chromatography, with carrene: methyl alcohol=50:1,25:1,15:1,5:1,2:1,1:1 is solvent gradient elution, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50:1,20:1,10:1,5:1,3:1,1:1 is solvent gradient elution, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtain42.3mg compound Hippolide J.
The preparation method of 14. sesterterpene compounds Hippolide Js according to claim 11, is characterized in that, described inThe preparation method of sesterterpene compounds Hippolide J comprise the steps:
(1) prepare bath sponge extract medicinal extract
1. prepare extract
Freezing bath sponge (Euspongiaofficinalis) dry weight 3.6kg is chopped into fritter, with 95% ethanol 20LDiacolation extracts 6 times, and each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 748g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains fat-soluble soakingCream 264g; Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtains oilEther position medicinal extract 99g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extract obtainsTo carrene position medicinal extract 135g;
2. carrene is extracted to medicinal extract 135g through decompression column chromatography, with carrene: methyl alcohol=50:1,25:1,15:1,5:1,2:1,1:1 is solvent gradient elution, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50:1,20:1,10:1,5:1,3:1,1:1 is solvent gradient elution, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtain37.9mg compound Hippolide J.
The preparation method of 15. sesterterpene compounds Hippolide Js according to claim 11, is characterized in that, described inThe preparation method of sesterterpene compounds Hippolide J comprise the steps:
(1) prepare Leucosolenia extract medicinal extract
1. prepare extract
Freezing Leucosolenia (Leucosolenia) dry weight 3.6kg is chopped into fritter, with 95% ethanol 20L diacolation extraction 6Inferior, each diacolation 3 days, merges extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 693g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains fat-soluble soakingCream 249g; Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtains oilEther position medicinal extract 94g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extract obtainsTo carrene position medicinal extract 128g;
2. carrene is extracted to medicinal extract 128g through decompression column chromatography, with carrene: methyl alcohol=50:1,25:1,15:1,5:1,2:1,1:1 is solvent gradient elution, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50:1,20:1,10:1,5:1,3:1,1:1 is solvent gradient elution, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtain63.1mg compound Hippolide J.
The preparation method of 16. sesterterpene compounds Hippolide Js according to claim 11, is characterized in that, described inThe preparation method of sesterterpene compounds Hippolide J comprise the steps:
(1) prepare sycon (Grantia) extract medicinal extract
1. prepare extract
Freezing sycon (Grantia) dry weight 3.6kg is chopped into fritter, with 95% ethanol 20L diacolation extraction 6 times, oozes at every turnFilter 3 days, merge extract;
2. prepare extract medicinal extract
Reduced pressure concentration said extracted liquid, obtains extract medicinal extract 739g;
(2) separation and purification
1. said extracted thing medicinal extract suspendible is scattered in water, is extracted with ethyl acetate 4 times, concentrated extract obtains fat-soluble soakingCream 273g; Fat-soluble medicinal extract is suspended in 90% methanol solution, with petroleum ether extraction 3 times, concentrated extract obtains oilEther position medicinal extract 102g; Add water the methanol concentration of suspension is adjusted to 60%, use dichloromethane extraction 3 times, concentrated extractObtain carrene position medicinal extract 146g;
2. carrene is extracted to medicinal extract 146g through decompression column chromatography, with carrene: methyl alcohol=50:1,25:1,15:1,5:1,2:1,1:1 is solvent gradient elution, obtains 9 component Fr.1~Fr.9 according to the similar stream part of TLC colour developing merging;
3. to the component Fr.5 column chromatography that again reduces pressure, with benzinum: ethyl acetate=50:1,20:1,10:1,5:1,3:1,1:1 is solvent gradient elution, and according to TLC, colour developing merges similar flow point, obtains Fr.10~Fr.14 totally 5 components;
4. component Fr.11 is carried out to positive and negative phase silica gel column chromatography, gel column chromatography repeatedly, then purify with high efficiency liquid phase, obtain73.9mg compound Hippolide J.
17. according to the sesterterpene compounds Hippolide J described in claim 1 or 11 in preparation in antitumor product shouldWith.
The application of 18. sesterterpene compounds Hippolide Js according to claim 17, is characterized in that, described productProduct are the one in anti-lung cancer product or anti-cervical cancer product, and described tumour is one or more in lung cancer or cervical carcinoma.
The application of 19. sesterterpene compounds Hippolide Js according to claim 18, is characterized in that, described is anti-Lung cancer product refers to the product that is directly used in prevention, diagnosis, detection, protection, treatment and research lung cancer and directly related disease thereofIn one or more, described lung cancer refers to one or more in non-small cell lung cancer and ED-SCLC, described is non-ED-SCLC is one or more in phosphorus cancer, gland cancer or maxicell lung cancer.
The application of 20. sesterterpene compounds Hippolide Js according to claim 18, is characterized in that, described is anti-Cervical carcinoma product refers to and is directly used in prevention, diagnosis, detection, protection, treatment and research cervical carcinoma and directly related disease thereofOne or more in product, described cervical carcinoma is under atypical hyperplasia, carcinoma in situ, mirror in early invasive carcinoma or infiltrating carcinomaOne or more.
The application of 21. sesterterpene compounds Hippolide Js according to claim 17, is characterized in that, described is anti-Tumour product is the one in medicine, reagent or food.
The application of 22. sesterterpene compounds Hippolide Js according to claim 21, is characterized in that, described is anti-Tumour product is medicine.
The application of 23. sesterterpene compounds Hippolide Js according to claim 17, is characterized in that, described twoPurity >=95% of sesquiterpenoids Hippolide J.
The application of 24. sesterterpene compounds Hippolide Js according to claim 17, is characterized in that, described twoThe occupation mode of sesquiterpenoids Hippolide J is use separately or combine the one in use with other chemical substances.
CN201110145099.0A 2011-05-31 2011-05-31 Sesterterpene compounds Hippolide J and its production and use Expired - Fee Related CN102617526B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110145099.0A CN102617526B (en) 2011-05-31 2011-05-31 Sesterterpene compounds Hippolide J and its production and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110145099.0A CN102617526B (en) 2011-05-31 2011-05-31 Sesterterpene compounds Hippolide J and its production and use

Publications (2)

Publication Number Publication Date
CN102617526A CN102617526A (en) 2012-08-01
CN102617526B true CN102617526B (en) 2016-05-18

Family

ID=46557786

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110145099.0A Expired - Fee Related CN102617526B (en) 2011-05-31 2011-05-31 Sesterterpene compounds Hippolide J and its production and use

Country Status (1)

Country Link
CN (1) CN102617526B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105541562B (en) * 2016-02-05 2021-10-29 林厚文 Sesquiterpene quinone compound Dysiherbols A and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1712028A (en) * 2004-06-24 2005-12-28 桐乡市恒发海绵有限公司 Chinese medicinal sponge, production and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1712028A (en) * 2004-06-24 2005-12-28 桐乡市恒发海绵有限公司 Chinese medicinal sponge, production and use thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Spongia属沐浴海绵活性成分及生理活性研究概况;林翠梧 赵树凯 蒋林斌;《天然产物研究与开发》;20011231;第13卷(第3期);第66-70页 *
沐浴海绵Spongia zimocca aubspecles irrgularia(Lendenfeld)活性成分的研究;陈芬 林翠梧 崔建国;《广西大学学报(自然科学版)》;20010331;第26卷(第1期);第116-118页 *
海绵Spongia sp.的化学成分研究;官智 曾陇梅;《中国中药杂志》;20100430;第35卷(第8期);第1004-1008页 *

Also Published As

Publication number Publication date
CN102617526A (en) 2012-08-01

Similar Documents

Publication Publication Date Title
Vásquez-Ocmín et al. Antiprotozoal activity of medicinal plants used by Iquitos-Nauta road communities in Loreto (Peru)
CN102603689B (en) Diterpene-kind compound Lachnin A and its production and use falls
CN102038721B (en) Pinus extract and application thereof
CN101554462B (en) Medicament for curing cancer
CN107551254A (en) A kind of Chinese medicine composition with preventing and treating Colon and rectum precancerous lesion and preparation method and application
CN102389437A (en) Application of Centella triterpenes in preparing products for improving cerebral apoplexy sequelae
CN105017438B (en) A kind of Radix et Rhizoma Gynurae divaricatae polysaccharide and its application in preparing for immunological regulation and anti-tumor drug and functional food
Niu et al. Inhibitory effect of saponins and polysaccharides from Radix ranunculit ternate on human gastric cancer BGC823 cells
CN105541562B (en) Sesquiterpene quinone compound Dysiherbols A and preparation method and application thereof
CN102617526B (en) Sesterterpene compounds Hippolide J and its production and use
CN102512431B (en) Application of centella asiatica triterpenoid component to preparing anti-craniocerebral injury product
CN102617596B (en) The black amber terpene of sesterterpene compounds I and its production and use
CN110123815A (en) The application of drug occurs as preparation treatment atrophic gastritis and/or blocking gastritis cancer conversion for Nuciferine and Lotus Leafextract
CN105878490B (en) Pharmaceutical composition for inhibiting tumor angiogenesis and preparation method thereof
CN105380955A (en) Application of rhaponiticin in medicine for treating ulcerative colitis
US20190070246A1 (en) Traditional chinese medicine composition and use thereof
CN100544736C (en) A kind of pharmaceutical composition of enhancing immunity and preparation method
CN103768570B (en) A kind of Chinese medicine composition for the treatment of acute cholecystitis and preparation method thereof
CN1824184A (en) Medicine for treating lung cancer
CN106822560A (en) Pharmaceutical composition and preparation method thereof
CN107029084A (en) A kind of Chinese medicine composition and its pharmaceutical preparation for treating Colon and rectum precancerous lesion and application
Rooney The story of medicine
CN104840747B (en) Chinese medicine composition with antithyroid cancer activity and its preparation method and application
CN108743598A (en) Application of the glucosides tobeimosides first in preparing huge pinocytosis derivant
CN102293767B (en) Application of active natural product B in preparing anti-vascular dementia products

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160518

Termination date: 20180531